| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lipase activity | ABHD3 PLA2G4D PLCB1 PLA2G4A PLCB3 PLCB4 PLA2G7 GPLD1 PLCZ1 LIPN LPL PNPLA8 | 8.09e-07 | 138 | 289 | 12 | GO:0016298 |
| GeneOntologyMolecularFunction | phospholipase activity | ABHD3 PLA2G4D PLCB1 PLA2G4A PLCB3 PLCB4 PLA2G7 GPLD1 PLCZ1 LPL PNPLA8 | 8.30e-07 | 114 | 289 | 11 | GO:0004620 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | NAT1 ABCA3 SLC39A11 ABCA9 RYR1 RYR2 ABCG4 GJA4 CLCN4 NALCN KCNC2 KCNC4 SV2B SV2A SERINC3 SLC37A2 CACNA1I TRPM1 SEC61A1 SLC23A2 CACNA1D CALHM5 HCN4 ANXA6 CLIC4 SLC13A3 GRIK5 CLIC6 PANX2 SLC40A1 SEC61A2 ABCG1 CACNA2D4 CATSPER1 SLC16A5 LRP6 SLC2A13 SLC5A8 ATP4B | 1.24e-06 | 1180 | 289 | 39 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | NAT1 ABCA3 SLC39A11 ABCA9 RYR1 RYR2 ABCG4 GJA4 CLCN4 NALCN KCNC2 KCNC4 SV2B SV2A SERINC3 SLC37A2 CACNA1I TRPM1 SEC61A1 SLC23A2 CACNA1D CALHM5 HCN4 ANXA6 CLIC4 SLC13A3 GRIK5 CLIC6 PANX2 SLC40A1 ATP8B2 SEC61A2 ABCG1 CACNA2D4 CATSPER1 SLC16A5 LRP6 SLC2A13 SLC5A8 ATP4B | 4.20e-06 | 1289 | 289 | 40 | GO:0005215 |
| GeneOntologyMolecularFunction | hypotaurine monooxygenase activity | 2.94e-05 | 5 | 289 | 3 | GO:0047822 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | RYR1 RYR2 GJA4 CLCN4 NALCN KCNC2 KCNC4 CACNA1I TRPM1 SEC61A1 CACNA1D CALHM5 HCN4 ANXA6 CLIC4 GRIK5 CLIC6 PANX2 CACNA2D4 CATSPER1 SLC5A8 | 2.94e-05 | 526 | 289 | 21 | GO:0022803 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 5.11e-05 | 145 | 289 | 10 | GO:0004713 | |
| GeneOntologyMolecularFunction | glucosidase activity | 5.17e-05 | 15 | 289 | 4 | GO:0015926 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC39A11 RYR1 RYR2 NALCN KCNC2 KCNC4 CACNA1I TRPM1 SEC61A1 SLC23A2 CACNA1D HCN4 SLC13A3 GRIK5 SLC40A1 CACNA2D4 CATSPER1 SLC5A8 ATP4B | 5.20e-05 | 465 | 289 | 19 | GO:0046873 |
| GeneOntologyMolecularFunction | N,N-dimethylaniline monooxygenase activity | 5.81e-05 | 6 | 289 | 3 | GO:0004499 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 8.29e-05 | 97 | 289 | 8 | GO:0008081 | |
| GeneOntologyMolecularFunction | channel activity | RYR1 RYR2 GJA4 CLCN4 NALCN KCNC2 KCNC4 CACNA1I TRPM1 SEC61A1 CACNA1D CALHM5 HCN4 ANXA6 CLIC4 GRIK5 CLIC6 PANX2 CACNA2D4 CATSPER1 | 8.68e-05 | 525 | 289 | 20 | GO:0015267 |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 1.01e-04 | 7 | 289 | 3 | GO:0090599 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | RYR1 RYR2 CLCN4 NALCN KCNC2 KCNC4 CACNA1I TRPM1 SEC61A1 CACNA1D CALHM5 HCN4 ANXA6 CLIC4 GRIK5 CLIC6 CACNA2D4 CATSPER1 | 1.37e-04 | 459 | 289 | 18 | GO:0005216 |
| GeneOntologyMolecularFunction | phospholipase A1 activity | 1.40e-04 | 19 | 289 | 4 | GO:0008970 | |
| GeneOntologyMolecularFunction | phospholipase A2 activity | 1.83e-04 | 37 | 289 | 5 | GO:0004623 | |
| GeneOntologyMolecularFunction | ABC-type sterol transporter activity | 2.09e-04 | 2 | 289 | 2 | GO:0034041 | |
| GeneOntologyMolecularFunction | trimethylamine monooxygenase activity | 2.09e-04 | 2 | 289 | 2 | GO:0034899 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 2.09e-04 | 2 | 289 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC39A11 RYR1 RYR2 CLCN4 NALCN KCNC2 KCNC4 CACNA1I TRPM1 SEC61A1 SLC23A2 CACNA1D CALHM5 HCN4 ANXA6 CLIC4 SLC13A3 GRIK5 CLIC6 SLC40A1 CACNA2D4 CATSPER1 SLC2A13 SLC5A8 ATP4B | 2.35e-04 | 793 | 289 | 25 | GO:0015075 |
| GeneOntologyMolecularFunction | calcium-independent phospholipase A2 activity | 2.36e-04 | 9 | 289 | 3 | GO:0047499 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC39A11 RYR1 RYR2 CLCN4 NALCN KCNC2 KCNC4 SLC37A2 CACNA1I TRPM1 SEC61A1 SLC23A2 CACNA1D HCN4 CLIC4 SLC13A3 GRIK5 CLIC6 SLC40A1 CACNA2D4 CATSPER1 SLC2A13 SLC5A8 ATP4B | 2.95e-04 | 758 | 289 | 24 | GO:0015318 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | PDE6A PDE6B ABHD3 PLA2G4D ELAC2 DDX1 FASN PTPN9 PTPRG PLCB1 PLA2G4A PLCB3 PLCB4 PLA2G7 DXO GPLD1 PLCZ1 CTDSPL2 LARS1 LIPN PTPRU PPM1G LPL PNPLA8 PDE7B | 3.06e-04 | 807 | 289 | 25 | GO:0016788 |
| GeneOntologyMolecularFunction | structural constituent of eye lens | 3.63e-04 | 24 | 289 | 4 | GO:0005212 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 5.00e-04 | 26 | 289 | 4 | GO:0004435 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | RYR1 RYR2 NALCN KCNC2 KCNC4 CACNA1I TRPM1 SEC61A1 CACNA1D CALHM5 HCN4 GRIK5 CACNA2D4 CATSPER1 | 5.07e-04 | 343 | 289 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.17e-04 | 46 | 289 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.88e-04 | 129 | 289 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC39A11 RYR1 RYR2 NALCN KCNC2 KCNC4 CACNA1I TRPM1 SEC61A1 SLC23A2 CACNA1D CALHM5 HCN4 SLC13A3 GRIK5 SLC40A1 CACNA2D4 CATSPER1 SLC2A13 SLC5A8 ATP4B | 7.13e-04 | 664 | 289 | 21 | GO:0008324 |
| GeneOntologyMolecularFunction | phospholipase C activity | 7.67e-04 | 29 | 289 | 4 | GO:0004629 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC39A11 RYR1 RYR2 NALCN KCNC2 KCNC4 CACNA1I TRPM1 SEC61A1 SLC23A2 CACNA1D HCN4 SLC13A3 GRIK5 SLC40A1 CACNA2D4 CATSPER1 SLC2A13 SLC5A8 ATP4B | 8.57e-04 | 627 | 289 | 20 | GO:0022890 |
| GeneOntologyMolecularFunction | myosin light chain kinase activity | 1.23e-03 | 4 | 289 | 2 | GO:0004687 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.23e-03 | 4 | 289 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | acetyl-CoA binding | 1.23e-03 | 4 | 289 | 2 | GO:1905502 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | RYR1 CLCN4 KCNC2 KCNC4 CACNA1I CACNA1D HCN4 CACNA2D4 CATSPER1 | 1.38e-03 | 182 | 289 | 9 | GO:0005244 |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.43e-03 | 115 | 289 | 7 | GO:0004497 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | RYR1 CLCN4 KCNC2 KCNC4 CACNA1I CACNA1D HCN4 CACNA2D4 CATSPER1 | 1.48e-03 | 184 | 289 | 9 | GO:0022832 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.63e-03 | 151 | 289 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.70e-03 | 152 | 289 | 8 | GO:0022843 | |
| GeneOntologyMolecularFunction | NADP binding | 2.02e-03 | 62 | 289 | 5 | GO:0050661 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 2.03e-03 | 5 | 289 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 2.08e-03 | 157 | 289 | 8 | GO:0052689 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 2.45e-03 | 19 | 289 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.49e-03 | 65 | 289 | 5 | GO:0004714 | |
| GeneOntologyBiologicalProcess | glycerolipid catabolic process | 4.21e-07 | 70 | 279 | 9 | GO:0046503 | |
| GeneOntologyBiologicalProcess | glycerophospholipid catabolic process | 5.59e-07 | 37 | 279 | 7 | GO:0046475 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | MYLK SLC39A11 ACTN4 HEPH RYR1 RYR2 GJA4 CLCN4 NALCN KCNC2 KCNC4 PLCB1 CACNA1I PLCB3 TRPM1 PLCB4 SEC61A1 PLP1 SLC23A2 CNTN1 CACNA1D PLCZ1 CALHM5 TCN1 HCN4 ANXA6 CLIC4 SLC13A3 GRIK5 CLIC6 PANX2 SELENON SLC40A1 ATP8B2 OPRK1 CACNA2D4 CATSPER1 LHFPL5 SLC5A8 ATP4B LARGE1 | 1.51e-06 | 1374 | 279 | 41 | GO:0006811 |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | CMBL NAT1 CYP1B1 MYLK CYP2F1 CYP2S1 VAV1 GPLD1 FMO1 FMO2 FMO3 CRKL LPO SUFU | 2.15e-06 | 222 | 279 | 14 | GO:0071466 |
| GeneOntologyBiologicalProcess | metal ion transport | MYLK SLC39A11 ACTN4 HEPH RYR1 RYR2 GJA4 NALCN KCNC2 KCNC4 PLCB1 CACNA1I PLCB3 TRPM1 PLCB4 SEC61A1 PLP1 SLC23A2 CNTN1 CACNA1D PLCZ1 TCN1 HCN4 ANXA6 SLC13A3 SELENON SLC40A1 OPRK1 CACNA2D4 CATSPER1 SLC5A8 ATP4B LARGE1 | 2.16e-06 | 1000 | 279 | 33 | GO:0030001 |
| GeneOntologyBiologicalProcess | axon ensheathment in central nervous system | 4.73e-06 | 33 | 279 | 6 | GO:0032291 | |
| GeneOntologyBiologicalProcess | central nervous system myelination | 4.73e-06 | 33 | 279 | 6 | GO:0022010 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 6.45e-06 | 10 | 279 | 4 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 6.45e-06 | 10 | 279 | 4 | GO:0086015 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | MYLK SLC39A11 ACTN4 HEPH RYR1 RYR2 GJA4 NALCN KCNC2 KCNC4 PLCB1 CACNA1I PLCB3 TRPM1 PLCB4 SEC61A1 PLP1 SLC23A2 CNTN1 CACNA1D PLCZ1 CALHM5 TCN1 HCN4 ANXA6 SLC13A3 PANX2 SELENON SLC40A1 OPRK1 CACNA2D4 CATSPER1 SLC5A8 ATP4B LARGE1 | 7.14e-06 | 1157 | 279 | 35 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC39A11 ACTN4 RYR1 RYR2 CLCN4 NALCN KCNC2 KCNC4 PLCB1 CACNA1I PLCB3 TRPM1 PLCB4 SEC61A1 PLP1 SLC23A2 CACNA1D CALHM5 TCN1 HCN4 ANXA6 CLIC4 SLC13A3 GRIK5 CLIC6 PANX2 SELENON SLC40A1 ATP8B2 OPRK1 CACNA2D4 CATSPER1 ATP4B LARGE1 | 8.25e-06 | 1115 | 279 | 34 | GO:0034220 |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 1.00e-05 | 11 | 279 | 4 | GO:0086070 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine metabolic process | 1.05e-05 | 78 | 279 | 8 | GO:0046470 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 1.50e-05 | 24 | 279 | 5 | GO:0048015 | |
| GeneOntologyBiologicalProcess | phospholipid catabolic process | 1.61e-05 | 60 | 279 | 7 | GO:0009395 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC39A11 ACTN4 RYR1 RYR2 CLCN4 NALCN KCNC2 KCNC4 PLCB1 SLC37A2 CACNA1I PLCB3 TRPM1 PLCB4 SEC61A1 PLP1 SLC23A2 CACNA1D TCN1 HCN4 CLIC4 SLC13A3 CLIC6 SELENON SLC40A1 OPRK1 CACNA2D4 CATSPER1 SLC5A8 ATP4B LARGE1 | 2.15e-05 | 1017 | 279 | 31 | GO:0098660 |
| GeneOntologyBiologicalProcess | protein localization to juxtaparanode region of axon | 2.40e-05 | 5 | 279 | 3 | GO:0071205 | |
| GeneOntologyBiologicalProcess | muscle tissue development | ERBB3 XIRP1 MYLK RYR1 RYR2 MYORG TWIST1 MYLK3 MYOZ1 FES FGFR1 HCN4 CNTNAP1 SELENON TBX18 CNTNAP2 LRP6 PAX3 PAX7 LARGE1 EPHB1 | 2.59e-05 | 558 | 279 | 21 | GO:0060537 |
| GeneOntologyBiologicalProcess | glycerophospholipid metabolic process | ABCA3 ABHD3 PLA2G4D CHPT1 PIK3C2G PLCB1 PLA2G4A PLCB3 PLCB4 PLA2G7 GPLD1 PIGU LDLR PNPLA8 PIGM | 3.33e-05 | 320 | 279 | 15 | GO:0006650 |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | ABCA3 ABHD3 PLA2G4D CHPT1 PIK3C2G PLCB1 PLA2G4A PLCB3 PLCB4 PLA2G7 GPLD1 PIGU LDLR LPL PNPLA8 TNXB PIGM | 4.74e-05 | 410 | 279 | 17 | GO:0006644 |
| GeneOntologyBiologicalProcess | skeletal muscle fiber development | 4.98e-05 | 49 | 279 | 6 | GO:0048741 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine catabolic process | 5.25e-05 | 16 | 279 | 4 | GO:0034638 | |
| GeneOntologyBiologicalProcess | glial cell development | 5.70e-05 | 157 | 279 | 10 | GO:0021782 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | ABCA3 ABHD3 PLA2G4D CHPT1 PIK3C2G PLCB1 PLA2G4A PLCB3 PLCB4 PLA2G7 GPLD1 PIGU LDLR LPL PNPLA8 TNXB PIGM | 8.26e-05 | 429 | 279 | 17 | GO:0046486 |
| GeneOntologyBiologicalProcess | myotube cell development | 8.69e-05 | 54 | 279 | 6 | GO:0014904 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | CMBL NAT1 CYP1B1 ABCA3 MYLK CYP2F1 CYP2S1 RPTOR VAV3 VAV1 GPLD1 FMO1 FMO2 FMO3 CRKL MTHFR LPO CNTNAP2 SUFU | 1.06e-04 | 525 | 279 | 19 | GO:0009410 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | CYP1B1 CYP2F1 MGAT4A NAIP ABHD3 CYP2S1 PLA2G4D DCAF5 TWIST1 FASN RPTOR PLA2G4A SERINC3 FGFR1 PLP1 SLC23A2 ADIPOR2 FMO1 FMO2 FMO3 CYP27C1 APP SELENON MTHFR LPL LPO PNPLA8 ADI1 THNSL2 TNXB | 1.20e-04 | 1064 | 279 | 30 | GO:0006082 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.32e-04 | 141 | 279 | 9 | GO:0006805 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 1.43e-04 | 59 | 279 | 6 | GO:0007215 | |
| GeneOntologyBiologicalProcess | oligodendrocyte development | 1.43e-04 | 59 | 279 | 6 | GO:0014003 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-4 | 1.52e-04 | 38 | 279 | 5 | GO:0071353 | |
| GeneOntologyBiologicalProcess | platelet activating factor metabolic process | 1.94e-04 | 9 | 279 | 3 | GO:0046469 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 1.95e-04 | 40 | 279 | 5 | GO:1990806 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | CYP1B1 CYP2F1 ABHD3 CYP2S1 PLA2G4D DCAF5 TWIST1 FASN PLA2G4A PLP1 ADIPOR2 FMO1 FMO2 LPL PNPLA8 THNSL2 TNXB | 1.95e-04 | 461 | 279 | 17 | GO:0006631 |
| GeneOntologyBiologicalProcess | neuromuscular process controlling posture | 1.98e-04 | 22 | 279 | 4 | GO:0050884 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC39A11 ACTN4 RYR1 RYR2 NALCN KCNC2 KCNC4 PLCB1 CACNA1I PLCB3 TRPM1 PLCB4 SEC61A1 PLP1 SLC23A2 CACNA1D CALHM5 TCN1 HCN4 SLC13A3 SELENON SLC40A1 OPRK1 CACNA2D4 CATSPER1 ATP4B LARGE1 | 2.05e-04 | 942 | 279 | 27 | GO:0098655 |
| GeneOntologyBiologicalProcess | calcium ion transport | MYLK RYR1 RYR2 GJA4 NALCN PLCB1 CACNA1I PLCB3 TRPM1 PLCB4 SEC61A1 PLP1 CACNA1D PLCZ1 ANXA6 SELENON CACNA2D4 CATSPER1 | 2.13e-04 | 509 | 279 | 18 | GO:0006816 |
| GeneOntologyBiologicalProcess | response to interleukin-4 | 2.20e-04 | 41 | 279 | 5 | GO:0070670 | |
| GeneOntologyBiologicalProcess | muscle cell development | XIRP1 SYNPO2L ACTN4 RYR1 MYORG MYLK3 MYOZ1 CNTNAP1 SELENON TBX18 CNTNAP2 LARGE1 | 2.26e-04 | 259 | 279 | 12 | GO:0055001 |
| GeneOntologyBiologicalProcess | lipid catabolic process | CYP1B1 ABHD3 PLA2G4D TWIST1 PLCB1 PLA2G4A PLCB3 PLCB4 PLA2G7 GPLD1 PLCZ1 LIPN LDLR LPL PNPLA8 | 2.38e-04 | 382 | 279 | 15 | GO:0016042 |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | RYR1 MYORG TWIST1 MYOZ1 CNTNAP1 SELENON CNTNAP2 PAX3 PAX7 LARGE1 EPHB1 | 2.41e-04 | 223 | 279 | 11 | GO:0007519 |
| GeneOntologyBiologicalProcess | camera-type eye development | CYP1B1 PDE6A PDE6B TWIST1 TRPM1 SDK1 RPGRIP1L CLIC4 CRYGA CRYGB CRYGC CRYGD LCTL LRP6 LARGE1 EPHB1 | 2.45e-04 | 426 | 279 | 16 | GO:0043010 |
| GeneOntologyBiologicalProcess | cellular response to lipoprotein particle stimulus | 2.76e-04 | 43 | 279 | 5 | GO:0071402 | |
| GeneOntologyBiologicalProcess | glycerol ether metabolic process | 2.81e-04 | 24 | 279 | 4 | GO:0006662 | |
| GeneOntologyBiologicalProcess | ether lipid metabolic process | 2.81e-04 | 24 | 279 | 4 | GO:0046485 | |
| GeneOntologyBiologicalProcess | muscle organ development | ERBB3 MYLK RYR1 RYR2 MYORG TWIST1 MYOZ1 CNTNAP1 LAMA5 SELENON CNTNAP2 LRP6 PAX3 PAX7 LARGE1 EPHB1 | 3.16e-04 | 436 | 279 | 16 | GO:0007517 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC39A11 ACTN4 RYR1 RYR2 NALCN KCNC2 KCNC4 PLCB1 CACNA1I PLCB3 TRPM1 PLCB4 SEC61A1 PLP1 SLC23A2 CACNA1D TCN1 HCN4 SLC13A3 SELENON SLC40A1 OPRK1 CACNA2D4 CATSPER1 ATP4B LARGE1 | 3.45e-04 | 922 | 279 | 26 | GO:0098662 |
| GeneOntologyBiologicalProcess | protein localization to axon | 3.73e-04 | 11 | 279 | 3 | GO:0099612 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 3.73e-04 | 11 | 279 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | RYR1 MYORG TWIST1 MYOZ1 CNTNAP1 SELENON CNTNAP2 PAX3 PAX7 LARGE1 EPHB1 | 4.49e-04 | 240 | 279 | 11 | GO:0060538 |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 4.50e-04 | 27 | 279 | 4 | GO:0035235 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development, skeletal muscle fiber | 5.42e-04 | 3 | 279 | 2 | GO:0098529 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 5.42e-04 | 3 | 279 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid transmembrane transport | 5.42e-04 | 3 | 279 | 2 | GO:0015882 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 5.51e-04 | 171 | 279 | 9 | GO:0048593 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | CYP1B1 CYP2F1 MGAT4A NAIP ABHD3 CYP2S1 PLA2G4D DCAF5 TWIST1 FASN RPTOR PLA2G4A SERINC3 FGFR1 PLP1 SLC23A2 ADIPOR2 FMO1 FMO2 CYP27C1 APP SELENON MTHFR LPL PNPLA8 ADI1 THNSL2 TNXB | 5.61e-04 | 1058 | 279 | 28 | GO:0043436 |
| GeneOntologyBiologicalProcess | positive regulation of amyloid precursor protein catabolic process | 5.96e-04 | 29 | 279 | 4 | GO:1902993 | |
| GeneOntologyBiologicalProcess | ether metabolic process | 5.96e-04 | 29 | 279 | 4 | GO:0018904 | |
| GeneOntologyBiologicalProcess | glycerol ether biosynthetic process | 6.33e-04 | 13 | 279 | 3 | GO:0046504 | |
| GeneOntologyBiologicalProcess | ether lipid biosynthetic process | 6.33e-04 | 13 | 279 | 3 | GO:0008611 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | NAIP ABHD3 DCAF5 FASN PLA2G4A SERINC3 PLP1 FMO1 FMO3 MTHFR LPL PNPLA8 ADI1 THNSL2 | 6.62e-04 | 377 | 279 | 14 | GO:0016053 |
| GeneOntologyCellularComponent | lipoprotein particle | 2.62e-05 | 44 | 282 | 6 | GO:1990777 | |
| GeneOntologyCellularComponent | plasma lipoprotein particle | 2.62e-05 | 44 | 282 | 6 | GO:0034358 | |
| GeneOntologyCellularComponent | protein-lipid complex | 3.86e-05 | 47 | 282 | 6 | GO:0032994 | |
| GeneOntologyCellularComponent | cell-cell junction | XIRP1 MYLK SPTAN1 ACTN4 RASIP1 GJA4 SV2A VAV1 RPGRIP1L ANXA6 CNTNAP1 LAMA3 CLIC4 PANX2 PTPRU TEC APP TIAM1 CNTNAP2 TNK2 CDH7 | 5.74e-05 | 591 | 282 | 21 | GO:0005911 |
| GeneOntologyCellularComponent | main axon | 2.02e-04 | 89 | 282 | 7 | GO:0044304 | |
| GeneOntologyCellularComponent | cation channel complex | RYR1 RYR2 KCNC2 KCNC4 CACNA1I CACNA1D HCN4 GRIK5 CACNA2D4 CATSPER1 CNTNAP2 | 3.68e-04 | 235 | 282 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | paranodal junction | 3.70e-04 | 11 | 282 | 3 | GO:0033010 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.76e-04 | 46 | 282 | 5 | GO:0005891 | |
| GeneOntologyCellularComponent | calcium channel complex | 4.56e-04 | 73 | 282 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | RYR1 RYR2 NALCN KCNC2 KCNC4 CACNA1I CACNA1D HCN4 CLIC4 GRIK5 CLIC6 CACNA2D4 CATSPER1 CNTNAP2 | 6.63e-04 | 378 | 282 | 14 | GO:0034702 |
| Domain | Galactose-bd-like | EPHB4 CUL7 CPXM2 CNTNAP1 LAMA5 PTPRU CNTNAP2 CPXM1 EPHA10 EPHB1 | 1.41e-06 | 94 | 279 | 10 | IPR008979 |
| Domain | Glyco_hydro_31 | 1.65e-06 | 7 | 279 | 4 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.65e-06 | 7 | 279 | 4 | PS00129 | |
| Domain | Glyco_hydro_31 | 1.65e-06 | 7 | 279 | 4 | IPR000322 | |
| Domain | Beta/gamma_crystallin | 1.91e-06 | 15 | 279 | 5 | IPR001064 | |
| Domain | CRYSTALLIN_BETA_GAMMA | 1.91e-06 | 15 | 279 | 5 | PS50915 | |
| Domain | Crystall | 1.91e-06 | 15 | 279 | 5 | PF00030 | |
| Domain | XTALbg | 1.91e-06 | 15 | 279 | 5 | SM00247 | |
| Domain | PLC-beta_CS | 3.30e-06 | 3 | 279 | 3 | IPR009535 | |
| Domain | DUF1154 | 3.30e-06 | 3 | 279 | 3 | PF06631 | |
| Domain | G_crystallin-rel | 5.24e-06 | 18 | 279 | 5 | IPR011024 | |
| Domain | ConA-like_dom | LGALS14 RYR1 DDX1 RYR2 HERC1 ADGRD1 MID2 CNTNAP1 LAMA3 LAMA5 PTPRU EGFL6 CNTNAP2 WDFY3 | 5.68e-06 | 219 | 279 | 14 | IPR013320 |
| Domain | fn3 | EPHB4 MYLK DCC PTPRG SDK1 CNTN2 CNTN1 MID2 PTPRU TNXB EPHA10 EPHB1 | 6.00e-06 | 162 | 279 | 12 | PF00041 |
| Domain | Tyr_kinase_cat_dom | 6.64e-06 | 88 | 279 | 9 | IPR020635 | |
| Domain | TyrKc | 6.64e-06 | 88 | 279 | 9 | SM00219 | |
| Domain | Ion_trans_dom | RYR1 RYR2 NALCN KCNC2 KCNC4 CACNA1I TRPM1 CACNA1D HCN4 CATSPER1 | 8.18e-06 | 114 | 279 | 10 | IPR005821 |
| Domain | Ion_trans | RYR1 RYR2 NALCN KCNC2 KCNC4 CACNA1I TRPM1 CACNA1D HCN4 CATSPER1 | 8.18e-06 | 114 | 279 | 10 | PF00520 |
| Domain | - | 1.30e-05 | 73 | 279 | 8 | 2.60.120.260 | |
| Domain | PLC-beta | 1.30e-05 | 4 | 279 | 3 | IPR016280 | |
| Domain | PROTEIN_KINASE_TYR | 1.48e-05 | 97 | 279 | 9 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.48e-05 | 97 | 279 | 9 | IPR008266 | |
| Domain | FN3 | EPHB4 MYLK DCC PTPRG SDK1 CNTN2 CNTN1 MID2 PTPRU TNXB EPHA10 EPHB1 | 2.30e-05 | 185 | 279 | 12 | SM00060 |
| Domain | GLYCOSYL_HYDROL_F31_2 | 3.23e-05 | 5 | 279 | 3 | PS00707 | |
| Domain | Flavin_mOase | 3.23e-05 | 5 | 279 | 3 | IPR000960 | |
| Domain | DiMe-aniline_mOase | 3.23e-05 | 5 | 279 | 3 | IPR012143 | |
| Domain | FMO-like | 3.23e-05 | 5 | 279 | 3 | PF00743 | |
| Domain | Flavin_mOase-like | 3.23e-05 | 5 | 279 | 3 | IPR020946 | |
| Domain | FN3 | EPHB4 MYLK DCC PTPRG SDK1 CNTN2 CNTN1 MID2 PTPRU TNXB EPHA10 EPHB1 | 4.70e-05 | 199 | 279 | 12 | PS50853 |
| Domain | PLCYc | 5.84e-05 | 15 | 279 | 4 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 5.84e-05 | 15 | 279 | 4 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 5.84e-05 | 15 | 279 | 4 | PS50008 | |
| Domain | EF-hand_like | 5.84e-05 | 15 | 279 | 4 | PF09279 | |
| Domain | PI-PLC-Y | 5.84e-05 | 15 | 279 | 4 | PF00387 | |
| Domain | PI-PLC_fam | 5.84e-05 | 15 | 279 | 4 | IPR001192 | |
| Domain | PLC_EF-hand-like | 5.84e-05 | 15 | 279 | 4 | IPR015359 | |
| Domain | Glyco_hydro_31_AS | 6.38e-05 | 6 | 279 | 3 | IPR030458 | |
| Domain | FN3_dom | EPHB4 MYLK DCC PTPRG SDK1 CNTN2 CNTN1 MID2 PTPRU TNXB EPHA10 EPHB1 | 7.55e-05 | 209 | 279 | 12 | IPR003961 |
| Domain | Acyl_Trfase/lysoPLipase | 9.95e-05 | 17 | 279 | 4 | IPR016035 | |
| Domain | PLCXc | 1.26e-04 | 18 | 279 | 4 | SM00148 | |
| Domain | PI-PLC-X | 1.26e-04 | 18 | 279 | 4 | PF00388 | |
| Domain | Glycoside_hydrolase_SF | 1.34e-04 | 53 | 279 | 6 | IPR017853 | |
| Domain | Pkinase_Tyr | 1.40e-04 | 129 | 279 | 9 | PF07714 | |
| Domain | C2 | PLA2G4D PIK3C2G PLCB1 PLA2G4A PLCB3 PLCB4 PLCZ1 RPGRIP1L ESYT3 | 1.57e-04 | 131 | 279 | 9 | PF00168 |
| Domain | PIPLC_X_DOMAIN | 1.58e-04 | 19 | 279 | 4 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 1.58e-04 | 19 | 279 | 4 | IPR000909 | |
| Domain | - | 2.02e-04 | 57 | 279 | 6 | 1.20.120.350 | |
| Domain | Channel_four-helix_dom | 2.02e-04 | 57 | 279 | 6 | IPR027359 | |
| Domain | C2 | PLA2G4D PIK3C2G PLCB1 PLA2G4A PLCB3 PLCB4 PLCZ1 RPGRIP1L ESYT3 | 2.20e-04 | 137 | 279 | 9 | SM00239 |
| Domain | SecY_su_dom | 2.22e-04 | 2 | 279 | 2 | IPR023201 | |
| Domain | SECY_1 | 2.22e-04 | 2 | 279 | 2 | PS00755 | |
| Domain | SECY_2 | 2.22e-04 | 2 | 279 | 2 | PS00756 | |
| Domain | - | 2.22e-04 | 2 | 279 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 2.22e-04 | 2 | 279 | 2 | IPR019561 | |
| Domain | Plug_translocon | 2.22e-04 | 2 | 279 | 2 | PF10559 | |
| Domain | ABCG1 | 2.22e-04 | 2 | 279 | 2 | IPR020064 | |
| Domain | SecY | 2.22e-04 | 2 | 279 | 2 | PF00344 | |
| Domain | SecY/SEC61-alpha | 2.22e-04 | 2 | 279 | 2 | IPR002208 | |
| Domain | Pax7_C | 2.22e-04 | 2 | 279 | 2 | IPR022106 | |
| Domain | SecY_CS | 2.22e-04 | 2 | 279 | 2 | IPR030659 | |
| Domain | Pax7 | 2.22e-04 | 2 | 279 | 2 | PF12360 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.33e-04 | 138 | 279 | 9 | IPR001245 | |
| Domain | FA58C_3 | 2.39e-04 | 21 | 279 | 4 | PS50022 | |
| Domain | FA58C | 2.39e-04 | 21 | 279 | 4 | SM00231 | |
| Domain | FA58C_1 | 2.39e-04 | 21 | 279 | 4 | PS01285 | |
| Domain | FA58C_2 | 2.39e-04 | 21 | 279 | 4 | PS01286 | |
| Domain | C2 | PLA2G4D PIK3C2G PLCB1 PLA2G4A PLCB3 PLCB4 PLCZ1 RPGRIP1L ESYT3 | 2.88e-04 | 142 | 279 | 9 | PS50004 |
| Domain | - | PLA2G4D PIK3C2G PLCB1 PLA2G4A PLCB3 PLCB4 PLCZ1 RPGRIP1L ESYT3 | 3.91e-04 | 148 | 279 | 9 | 2.60.40.150 |
| Domain | F5_F8_type_C | 4.09e-04 | 24 | 279 | 4 | PF00754 | |
| Domain | FA58C | 4.09e-04 | 24 | 279 | 4 | IPR000421 | |
| Domain | - | 4.81e-04 | 25 | 279 | 4 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 4.81e-04 | 25 | 279 | 4 | IPR017946 | |
| Domain | - | 5.55e-04 | 95 | 279 | 7 | 2.60.120.200 | |
| Domain | EGF-like_CS | EPHB4 TPO CNTNAP1 LAMA3 LAMA5 LDLR EGFL6 CNTNAP2 LRP6 TNXB EPHA10 EPHB1 | 5.85e-04 | 261 | 279 | 12 | IPR013032 |
| Domain | SV2 | 6.60e-04 | 3 | 279 | 2 | IPR022308 | |
| Domain | Vav | 6.60e-04 | 3 | 279 | 2 | IPR028530 | |
| Domain | RyR | 6.60e-04 | 3 | 279 | 2 | PF02026 | |
| Domain | Pentapeptide_4 | 6.60e-04 | 3 | 279 | 2 | PF13599 | |
| Domain | RR_TM4-6 | 6.60e-04 | 3 | 279 | 2 | PF06459 | |
| Domain | Ryan_recept | 6.60e-04 | 3 | 279 | 2 | IPR013333 | |
| Domain | Ryanodine_rcpt | 6.60e-04 | 3 | 279 | 2 | IPR003032 | |
| Domain | PLC-beta_C | 6.60e-04 | 3 | 279 | 2 | PF08703 | |
| Domain | Ryanrecept_TM4-6 | 6.60e-04 | 3 | 279 | 2 | IPR009460 | |
| Domain | PLC-beta_C | 6.60e-04 | 3 | 279 | 2 | IPR014815 | |
| Domain | EGF_2 | EPHB4 TPO CNTNAP1 LAMA3 LAMA5 LDLR EGFL6 CNTNAP2 LRP6 TNXB EPHA10 EPHB1 | 6.69e-04 | 265 | 279 | 12 | PS01186 |
| Domain | C2_dom | PLA2G4D PIK3C2G PLCB1 PLA2G4A PLCB3 PLCB4 PLCZ1 RPGRIP1L ESYT3 | 8.21e-04 | 164 | 279 | 9 | IPR000008 |
| Domain | - | EPHB4 TARM1 MYLK HLA-DMB RBPJL GBE1 DCC IL18R1 FAM187B PTPRG PKHD1 FGFR1 CAMTA1 SDK1 CNTN2 CNTN1 MID2 PTPRU TNXB EPHA10 EPHB1 | 1.03e-03 | 663 | 279 | 21 | 2.60.40.10 |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.06e-03 | 14 | 279 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.06e-03 | 14 | 279 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.06e-03 | 14 | 279 | 3 | IPR001426 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.06e-03 | 14 | 279 | 3 | IPR001090 | |
| Domain | Eph_TM | 1.06e-03 | 14 | 279 | 3 | IPR027936 | |
| Domain | EphA2_TM | 1.06e-03 | 14 | 279 | 3 | PF14575 | |
| Domain | EPH_lbd | 1.06e-03 | 14 | 279 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 1.06e-03 | 14 | 279 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.06e-03 | 14 | 279 | 3 | IPR016257 | |
| Domain | EPH_LBD | 1.06e-03 | 14 | 279 | 3 | PS51550 | |
| Domain | Glyco_hydro_31_CS | 1.31e-03 | 4 | 279 | 2 | IPR030459 | |
| Domain | Gal_mutarotase_N | 1.31e-03 | 4 | 279 | 2 | IPR031727 | |
| Domain | K_chnl_volt-dep_Kv3 | 1.31e-03 | 4 | 279 | 2 | IPR003974 | |
| Domain | 5peptide_repeat | 1.31e-03 | 4 | 279 | 2 | IPR001646 | |
| Pathway | WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS | 3.42e-05 | 5 | 215 | 3 | M39449 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 6.76e-05 | 6 | 215 | 3 | M47548 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | ERBB3 MYLK RYR1 RYR2 MYLK3 PLCB1 CACNA1I PLCB3 PLCB4 CACNA1D PLCZ1 | 9.03e-05 | 178 | 215 | 11 | M2890 |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.07e-04 | 17 | 215 | 4 | MM14552 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY | 1.17e-04 | 7 | 215 | 3 | M47505 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.19e-04 | 51 | 215 | 6 | M27311 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.36e-04 | 18 | 215 | 4 | M524 | |
| Pubmed | 5.00e-09 | 4 | 294 | 4 | 3428594 | ||
| Pubmed | 5.00e-09 | 4 | 294 | 4 | 12507494 | ||
| Pubmed | Differential regulation of gamma-crystallin genes during mouse lens development. | 5.00e-09 | 4 | 294 | 4 | 3792630 | |
| Pubmed | Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts. | 5.00e-09 | 4 | 294 | 4 | 12011157 | |
| Pubmed | 5.00e-09 | 4 | 294 | 4 | 15037589 | ||
| Pubmed | 5.00e-09 | 4 | 294 | 4 | 3011643 | ||
| Pubmed | Temporal regulation of six crystallin transcripts during mouse lens development. | 5.00e-09 | 4 | 294 | 4 | 1623964 | |
| Pubmed | 2.49e-08 | 5 | 294 | 4 | 9426193 | ||
| Pubmed | 2.49e-08 | 5 | 294 | 4 | 10627816 | ||
| Pubmed | 5.08e-08 | 13 | 294 | 5 | 36793543 | ||
| Pubmed | Human gamma-crystallin genes. A gene family on its way to extinction. | 7.41e-08 | 6 | 294 | 4 | 2258929 | |
| Pubmed | Gamma-crystallins of the human eye lens: expression analysis of five members of the gene family. | 7.41e-08 | 6 | 294 | 4 | 3670288 | |
| Pubmed | 1.72e-07 | 7 | 294 | 4 | 19458237 | ||
| Pubmed | HSF4 is required for normal cell growth and differentiation during mouse lens development. | 2.38e-07 | 17 | 294 | 5 | 15483628 | |
| Pubmed | 5.40e-07 | 83 | 294 | 8 | 11114734 | ||
| Pubmed | The gamma-crystallins and human cataracts: a puzzle made clearer. | 5.98e-07 | 3 | 294 | 3 | 10521291 | |
| Pubmed | Multiple gamma-crystallins of the mouse lens: fractionation of mRNAs by cDNA cloning. | 5.98e-07 | 3 | 294 | 3 | 6953430 | |
| Pubmed | Three murine cataract mutants (Cat2) are defective in different gamma-crystallin genes. | 5.98e-07 | 3 | 294 | 3 | 9782080 | |
| Pubmed | 5.98e-07 | 3 | 294 | 3 | 12876325 | ||
| Pubmed | 5.98e-07 | 3 | 294 | 3 | 30647129 | ||
| Pubmed | ABCG1 and ABCG4 Suppress γ-Secretase Activity and Amyloid β Production. | 5.98e-07 | 3 | 294 | 3 | 27196068 | |
| Pubmed | 5.98e-07 | 3 | 294 | 3 | 30381441 | ||
| Pubmed | Gamma-crystallin family of the mouse lens: structural and evolutionary relationships. | 5.98e-07 | 3 | 294 | 3 | 6096855 | |
| Pubmed | 7.60e-07 | 21 | 294 | 5 | 30270038 | ||
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 1.01e-06 | 90 | 294 | 8 | 16273093 | |
| Pubmed | Sox1 directly regulates the gamma-crystallin genes and is essential for lens development in mice. | 1.01e-06 | 10 | 294 | 4 | 9512512 | |
| Pubmed | Regulation of lens fiber cell differentiation by transcription factor c-Maf. | 1.01e-06 | 10 | 294 | 4 | 10383433 | |
| Pubmed | 1.58e-06 | 11 | 294 | 4 | 10595510 | ||
| Pubmed | 1.58e-06 | 11 | 294 | 4 | 12446761 | ||
| Pubmed | 1.58e-06 | 11 | 294 | 4 | 11146559 | ||
| Pubmed | HLA-DMB PTPRG CLU FGFR1 CNTN2 CNTN1 GPLD1 TCN1 ADAMTS13 APP LDLR TNXB | 2.26e-06 | 257 | 294 | 12 | 16335952 | |
| Pubmed | Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. | 2.35e-06 | 12 | 294 | 4 | 12426373 | |
| Pubmed | 2.38e-06 | 4 | 294 | 3 | 22232929 | ||
| Pubmed | 2.38e-06 | 4 | 294 | 3 | 8626090 | ||
| Pubmed | 2.38e-06 | 4 | 294 | 3 | 9753089 | ||
| Pubmed | Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. | 2.38e-06 | 4 | 294 | 3 | 9305844 | |
| Pubmed | 2.38e-06 | 4 | 294 | 3 | 15174099 | ||
| Pubmed | Phospholipase C-β1 potentiates glucose-stimulated insulin secretion. | 2.38e-06 | 4 | 294 | 3 | 31268747 | |
| Pubmed | Two adhesive systems cooperatively regulate axon ensheathment and myelin growth in the CNS. | 2.38e-06 | 4 | 294 | 3 | 31641127 | |
| Pubmed | 2.38e-06 | 4 | 294 | 3 | 23006664 | ||
| Pubmed | Quantitative analysis of FMO gene mRNA levels in human tissues. | 2.38e-06 | 4 | 294 | 3 | 16183778 | |
| Pubmed | 2.38e-06 | 4 | 294 | 3 | 20621668 | ||
| Pubmed | CNS myelin paranodes require Nkx6-2 homeoprotein transcriptional activity for normal structure. | 3.37e-06 | 13 | 294 | 4 | 15601927 | |
| Pubmed | TBC1D5 SPTAN1 DHX38 ACTN4 CUL7 PTPN9 GANAB TXNDC5 PTPRG HERC1 SEC61A1 RPGRIP1L PDPR CTDSPL2 CEP192 ARHGAP39 PTPRU APP PPM1G ARHGAP5 FAM171A2 TIAM1 AIFM1 LRP6 SUFU | 3.81e-06 | 1049 | 294 | 25 | 27880917 | |
| Pubmed | 4.17e-06 | 77 | 294 | 7 | 22973453 | ||
| Pubmed | The orchestration of mammalian tissue morphogenesis through a series of coherent feed-forward loops. | 4.68e-06 | 14 | 294 | 4 | 21998302 | |
| Pubmed | Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine. | 5.90e-06 | 5 | 294 | 3 | 32156684 | |
| Pubmed | Amyloid precursor protein regulates netrin-1-mediated commissural axon outgrowth. | 5.90e-06 | 5 | 294 | 3 | 22782894 | |
| Pubmed | 5.90e-06 | 5 | 294 | 3 | 8311461 | ||
| Pubmed | 5.90e-06 | 5 | 294 | 3 | 8128486 | ||
| Pubmed | Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. | 5.90e-06 | 5 | 294 | 3 | 23584088 | |
| Pubmed | 6.35e-06 | 15 | 294 | 4 | 10080188 | ||
| Pubmed | 8.40e-06 | 16 | 294 | 4 | 27223328 | ||
| Pubmed | 8.40e-06 | 16 | 294 | 4 | 15593327 | ||
| Pubmed | 1.17e-05 | 6 | 294 | 3 | 8739298 | ||
| Pubmed | 1.17e-05 | 6 | 294 | 3 | 2841328 | ||
| Pubmed | A new region of conservation is defined between human and mouse X chromosomes. | 1.17e-05 | 6 | 294 | 3 | 8661129 | |
| Pubmed | 1.17e-05 | 6 | 294 | 3 | 12527699 | ||
| Pubmed | Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. | 1.17e-05 | 6 | 294 | 3 | 16687515 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | MARS1 RYR1 RPTOR PKHD1 TRPM1 SEC61A1 DOCK10 HELQ AIFM1 DOP1A | 1.23e-05 | 208 | 294 | 10 | 33230847 |
| Pubmed | 1.39e-05 | 18 | 294 | 4 | 33514739 | ||
| Pubmed | Regulation of ocular lens development by Smad-interacting protein 1 involving Foxe3 activation. | 1.39e-05 | 18 | 294 | 4 | 16162653 | |
| Pubmed | 1.39e-05 | 18 | 294 | 4 | 1979339 | ||
| Pubmed | Feto-maternal cholesterol transport regulated by β-Klotho-FGF15 axis is essential for fetal growth. | 1.75e-05 | 19 | 294 | 4 | 37541847 | |
| Pubmed | Genetic dissection of gustatory sensitivity to bitterness (sucrose octaacetate) in mice. | 2.04e-05 | 7 | 294 | 3 | 10609087 | |
| Pubmed | 2.04e-05 | 7 | 294 | 3 | 12821674 | ||
| Pubmed | Migration and synaptogenesis of cone photoreceptors in the developing mouse retina. | 2.04e-05 | 7 | 294 | 3 | 9364238 | |
| Pubmed | 2.04e-05 | 7 | 294 | 3 | 2482828 | ||
| Pubmed | 2.04e-05 | 7 | 294 | 3 | 12975355 | ||
| Pubmed | EPHB4 SPTAN1 ECD DCAF5 ELAC2 GANAB TXNDC5 ERAP2 CLU CLPTM1 BYSL SAMM50 SEC61A1 DPH1 TBC1D15 PDPR AHCTF1 CEP192 ZFC3H1 APP PIGU PPM1G SEC61A2 FAM171A2 TIAM1 AIFM1 PPP1R15B PNPLA8 ADI1 | 2.86e-05 | 1487 | 294 | 29 | 33957083 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | ABCA3 ACTN4 SPG21 JAK1 GJA4 PTPN9 CHPT1 SV2A CLPTM1 SERINC3 PLP1 CNTN1 CNTNAP1 PRRT2 APP PIGU TM7SF2 PIGM | 3.20e-05 | 697 | 294 | 18 | 28298427 |
| Pubmed | 3.24e-05 | 8 | 294 | 3 | 16289966 | ||
| Pubmed | Adhesion molecule Amigo2 is involved in the fasciculation process of the fasciculus retroflexus. | 3.24e-05 | 8 | 294 | 3 | 35727300 | |
| Pubmed | 3.24e-05 | 8 | 294 | 3 | 17884558 | ||
| Pubmed | Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. | 3.39e-05 | 72 | 294 | 6 | 8075499 | |
| Pubmed | A gene expression resource generated by genome-wide lacZ profiling in the mouse. | 3.46e-05 | 44 | 294 | 5 | 26398943 | |
| Pubmed | 3.67e-05 | 73 | 294 | 6 | 24728074 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB4 B3GALNT1 CYP1B1 DPY19L3 NCAPH2 ELAC2 DDX1 MYORG NXPE3 GANAB TXNDC5 CHPT1 CLU CLPTM1 UTP20 SEC61A1 CNTNAP1 LAMA5 APP PIGU SELENON LDLR ZDHHC6 LPL LRP6 | 3.69e-05 | 1201 | 294 | 25 | 35696571 |
| Pubmed | Hedgehog signalling controls sinoatrial node development and atrioventricular cushion formation. | 4.65e-05 | 24 | 294 | 4 | 34062094 | |
| Pubmed | 4.84e-05 | 9 | 294 | 3 | 20005821 | ||
| Pubmed | 4.84e-05 | 9 | 294 | 3 | 7589147 | ||
| Pubmed | 4.84e-05 | 9 | 294 | 3 | 10501179 | ||
| Pubmed | DCAF5 GANAB SV2B SV2A CAMTA1 CLEC16A SLC23A2 WDR7 DOCK10 ARHGEF12 CEP192 ARFGEF3 LARGE1 | 4.98e-05 | 407 | 294 | 13 | 12693553 | |
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 5.50e-05 | 25 | 294 | 4 | 15254900 | |
| Pubmed | 6.61e-05 | 81 | 294 | 6 | 39217171 | ||
| Pubmed | 6.87e-05 | 10 | 294 | 3 | 21972064 | ||
| Pubmed | Expression of phospholipase C isozymes by murine B lymphocytes. | 6.87e-05 | 10 | 294 | 3 | 2033248 | |
| Pubmed | Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. | 6.87e-05 | 10 | 294 | 3 | 22424946 | |
| Pubmed | 6.87e-05 | 10 | 294 | 3 | 23295235 | ||
| Pubmed | 7.12e-05 | 2 | 294 | 2 | 20019163 | ||
| Pubmed | A locus for a human hereditary cataract is closely linked to the gamma-crystallin gene family. | 7.12e-05 | 2 | 294 | 2 | 3025877 | |
| Pubmed | B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin. | 7.12e-05 | 2 | 294 | 2 | 19586920 | |
| Pubmed | 7.12e-05 | 2 | 294 | 2 | 12087094 | ||
| Pubmed | 7.12e-05 | 2 | 294 | 2 | 20372818 | ||
| Pubmed | Clusterin (Apo J) protects against in vitro amyloid-beta (1-40) neurotoxicity. | 7.12e-05 | 2 | 294 | 2 | 8752142 | |
| Pubmed | Human flavin-containing monooxygenase 1 and its long-sought hydroperoxyflavin intermediate. | 7.12e-05 | 2 | 294 | 2 | 34509493 | |
| Pubmed | Regulation of mouse liver flavin-containing monooxygenases 1 and 3 by sex steroids. | 7.12e-05 | 2 | 294 | 2 | 9186481 | |
| Pubmed | 7.12e-05 | 2 | 294 | 2 | 26119586 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 7.12e-05 | 2 | 294 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 7.12e-05 | 2 | 294 | 2 | 26009179 | |
| Interaction | SH3BP2 interactions | 3.64e-06 | 48 | 274 | 7 | int:SH3BP2 | |
| Interaction | OPALIN interactions | MICOS13 SLC39A11 CYP2S1 JAK1 CHPT1 RPTOR UTP20 AHCTF1 ECPAS SEC61A2 FAM171A2 WDFY3 PIGM | 6.09e-06 | 209 | 274 | 13 | int:OPALIN |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE11 SPDYE13 SPDYE15 SPDYE14 SPDYE17 SPDYE10 SPDYE9 SPDYE12 SPDYE8 | 7.25e-05 | 271 | 295 | 9 | chr7q11 |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 3.97e-08 | 19 | 199 | 6 | 832 | |
| GeneFamily | Fibronectin type III domain containing | EPHB4 MYLK DCC PTPRG SDK1 CNTN2 CNTN1 MID2 PTPRU TNXB EPHA10 EPHB1 | 2.11e-07 | 160 | 199 | 12 | 555 |
| GeneFamily | Phospholipases | 3.43e-07 | 42 | 199 | 7 | 467 | |
| GeneFamily | Beta-gamma crystallins | 1.77e-05 | 15 | 199 | 4 | 1359 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 2.69e-04 | 12 | 199 | 3 | 756 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.59e-04 | 3 | 199 | 2 | 287 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 4.37e-04 | 14 | 199 | 3 | 1095 | |
| GeneFamily | SH2 domain containing | 8.78e-04 | 101 | 199 | 6 | 741 | |
| GeneFamily | Blood group antigens|CD molecules|ATP binding cassette subfamily G | 1.18e-03 | 5 | 199 | 2 | 811 | |
| GeneFamily | Chloride intracellular channels | 1.76e-03 | 6 | 199 | 2 | 307 | |
| GeneFamily | Phosphodiesterases | 2.24e-03 | 24 | 199 | 3 | 681 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.83e-03 | 26 | 199 | 3 | 253 | |
| GeneFamily | Paired boxes | 4.12e-03 | 9 | 199 | 2 | 675 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DCC RYR2 SORCS1 PIK3C2G PKHD1 DNAH9 SDK1 CNTN2 CNTN1 MGAM ARFGEF3 EPHA10 | 3.47e-09 | 184 | 291 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DCC RYR2 SORCS1 PIK3C2G PKHD1 DNAH9 SDK1 CNTN2 CNTN1 MGAM ARFGEF3 EPHA10 | 3.47e-09 | 184 | 291 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DCC RYR2 SORCS1 PIK3C2G PKHD1 DNAH9 SDK1 CNTN2 CNTN1 MGAM ARFGEF3 EPHA10 | 3.47e-09 | 184 | 291 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 NALCN PIK3C2G PKHD1 ADGRD1 CNTN1 CNTNAP1 TBX18 CACNA2D4 TIAM1 PDE7B CDH7 | 7.48e-09 | 197 | 291 | 12 | 6806ec223e542f0475303698eb78c1cc527f5c6b |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | GBE1 KCNC2 PLA2G4A VAV3 NMBR ST6GALNAC5 CNTNAP2 LHFPL5 CDH7 B3GAT2 | 1.98e-08 | 134 | 291 | 10 | 657ad905b40ec3f82acdef824431b8276d291ef7 |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | TARM1 MYLK SYNPO2L ABCA9 RYR2 PTPRG SLC40A1 TBX18 HHIPL1 TNXB | 1.00e-07 | 159 | 291 | 10 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | TWIST1 SORCS1 HOXA7 FES PLA2G4A PLCB4 ADGRD1 APP TIAM1 CPXM1 | 1.50e-07 | 166 | 291 | 10 | 773673a5d0430640439845b264740bfbbdad0cb2 |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | B3GALNT1 HLA-DMB IL18R1 HOXA7 KLHL23 FES VAV3 CATSPER1 ST6GALNAC5 TEC | 3.03e-07 | 179 | 291 | 10 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.71e-07 | 183 | 291 | 10 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 5.24e-07 | 190 | 291 | 10 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-07 | 192 | 291 | 10 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ABCA3 FASN PTPRG ADGRD1 PMM1 GPLD1 LAMA3 LDLR ARFGEF3 LARGE1 | 6.34e-07 | 194 | 291 | 10 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | MYLK ABCA9 RYR2 PTPRG SDK1 CACNA1D FMO2 SLC40A1 ST6GALNAC5 TNXB | 6.65e-07 | 195 | 291 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 8.37e-07 | 200 | 291 | 10 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.37e-07 | 200 | 291 | 10 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 160 | 291 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 160 | 291 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-06 | 167 | 291 | 9 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 1.69e-06 | 168 | 291 | 9 | d02eba7ece17edcdd47fd6b784c93910ce61090f | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | ERBB3 TMEM132B SORCS1 CLU PLCB1 PLP1 CYP27C1 CLIC4 ST6GALNAC5 | 1.77e-06 | 169 | 291 | 9 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 169 | 291 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.86e-06 | 170 | 291 | 9 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-06 | 174 | 291 | 9 | 0a8fa44604be19fbac722ebc6d1cd72b71be7022 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.47e-06 | 176 | 291 | 9 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.47e-06 | 176 | 291 | 9 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D231|Adult / Lineage, Cell type, age group and donor | 2.56e-06 | 132 | 291 | 8 | 8d30b71776f5f6da55dc78e0c5cb27be460004e3 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.72e-06 | 178 | 291 | 9 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 179 | 291 | 9 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MGAT4A ABCA9 SERINC3 SLC37A2 FERMT3 PLA2G7 MRC1 SLC13A3 SLC40A1 | 2.98e-06 | 180 | 291 | 9 | a600bc705993d3a010550a25d3b54358946f061f |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.26e-06 | 182 | 291 | 9 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 185 | 291 | 9 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 185 | 291 | 9 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 185 | 291 | 9 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-06 | 185 | 291 | 9 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.72e-06 | 185 | 291 | 9 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.89e-06 | 186 | 291 | 9 | 4e983de6d2515082f9e555f4f949cec84281c140 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.07e-06 | 187 | 291 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.07e-06 | 187 | 291 | 9 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 190 | 291 | 9 | 68ba1934b2b3f0cec8efd229fe1db6e8be8a26b0 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 190 | 291 | 9 | 010d7d13a3c16e614c36720ef690a505b9f3f7aa | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-06 | 192 | 291 | 9 | 3fc7a661ef39286abfd82ed8ab580011f01cb8fd | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 5.04e-06 | 192 | 291 | 9 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | CYP1B1 SV2B FGFR1 CALHM5 CYP27C1 CNTNAP1 PCDHB7 ATP8B2 HHIPL1 | 5.25e-06 | 193 | 291 | 9 | 194e7fa00a50cc4e026987b715323d125d79594e |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.25e-06 | 193 | 291 | 9 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.42e-06 | 146 | 291 | 8 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.48e-06 | 194 | 291 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.71e-06 | 195 | 291 | 9 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-06 | 195 | 291 | 9 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | VE-NK|VE / Condition, Cell_class and T cell subcluster | 6.20e-06 | 197 | 291 | 9 | cae6ff8763501e7a5897b50188ac2640d65a47c0 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Others-HSPC|COVID-19_Convalescent / Disease, condition lineage and cell class | EPHB4 B3GALNT1 HOXA7 SV2A KLHL23 PLA2G4A SLC40A1 CPXM1 TSSK4 | 6.20e-06 | 197 | 291 | 9 | c1033a1a8b8b5c8569130aa9405a6e8e65ef7bd0 |
| ToppCell | VE-NK-|VE / Condition, Cell_class and T cell subcluster | 6.20e-06 | 197 | 291 | 9 | ee89b8521fb4faaed9e4d39f7171e45eccf38b00 | |
| ToppCell | RV-16._Neuronal|World / Chamber and Cluster_Paper | ERBB3 TMEM132B SORCS1 PLP1 CNTN1 CYP27C1 CACNA2D4 ST6GALNAC5 | 6.30e-06 | 149 | 291 | 8 | 3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.46e-06 | 198 | 291 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 6.73e-06 | 199 | 291 | 9 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.73e-06 | 199 | 291 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | distal-1-mesenchymal-Lipofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.73e-06 | 199 | 291 | 9 | a8293db3c42a8d30897858b49aae7acfc18663ba | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.01e-06 | 200 | 291 | 9 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 7.01e-06 | 200 | 291 | 9 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 7.01e-06 | 200 | 291 | 9 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 7.01e-06 | 200 | 291 | 9 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 7.01e-06 | 200 | 291 | 9 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.01e-06 | 200 | 291 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 7.01e-06 | 200 | 291 | 9 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | ERBB3 TMEM132B SORCS1 PLP1 CNTN1 CYP27C1 CACNA2D4 ST6GALNAC5 | 7.65e-06 | 153 | 291 | 8 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-06 | 156 | 291 | 8 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 9.24e-06 | 157 | 291 | 8 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.01e-05 | 159 | 291 | 8 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 161 | 291 | 8 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 161 | 291 | 8 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 161 | 291 | 8 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 161 | 291 | 8 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | Club-club-6|World / Class top | 1.12e-05 | 77 | 291 | 6 | 3653cf20b1b312578a54ffd33e75a8b92874f9bf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 164 | 291 | 8 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | lung-Club_Cells|lung / shred on tissue and cell subclass | 1.27e-05 | 164 | 291 | 8 | b12cacd499b18b96120ca6d14646aebeaed41d10 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-05 | 167 | 291 | 8 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 1.45e-05 | 167 | 291 | 8 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-05 | 167 | 291 | 8 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.51e-05 | 168 | 291 | 8 | 03c95ad3684caec7a6d581006b237cc5fa230685 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 1.51e-05 | 168 | 291 | 8 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 1.51e-05 | 168 | 291 | 8 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 169 | 291 | 8 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 169 | 291 | 8 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 169 | 291 | 8 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 170 | 291 | 8 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 170 | 291 | 8 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.65e-05 | 170 | 291 | 8 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 171 | 291 | 8 | 05fcc72df50a380a913821b5781d9621df37d328 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 171 | 291 | 8 | 48fc4eca18b102b5ec5050f758281292ee8e10c6 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 171 | 291 | 8 | 25493a4a7b636920e2cfd984542cc500709c9dcf | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 171 | 291 | 8 | 508b41e3ad2638f9dd546d251b13ff60fc8c3207 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.79e-05 | 172 | 291 | 8 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 125 | 291 | 7 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 173 | 291 | 8 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.87e-05 | 173 | 291 | 8 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.87e-05 | 173 | 291 | 8 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | ERBB3 TMEM132B SORCS1 PLP1 CNTN1 CYP27C1 ARHGAP39 ST6GALNAC5 | 1.87e-05 | 173 | 291 | 8 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.12e-05 | 176 | 291 | 8 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 177 | 291 | 8 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 177 | 291 | 8 | 32fecefba1a55e1f418c9a055236fa11175c692d | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 177 | 291 | 8 | 1b153fbfe1323dc589de4af73a52149ea5ce6763 | |
| Drug | caffeine | NAT1 CYP1B1 PDE6A MYLK CYP2F1 PDE6B CYP2S1 RYR1 RYR2 RPTOR PLCB1 CACNA1I PLCB3 PLCB4 SEC61A1 GPLD1 CACNA1D PLCZ1 MGAM FMO1 FMO3 GRIK5 PPM1G SEC61A2 CACNA2D4 CATSPER1 PDE7B | 2.21e-09 | 562 | 282 | 27 | CID000002519 |
| Drug | papaverine | PDE6A PDE6B RYR1 RYR2 PLCB1 CACNA1I PLCB3 PLCB4 GPLD1 CACNA1D PLCZ1 CACNA2D4 CATSPER1 PDE7B | 4.46e-08 | 176 | 282 | 14 | CID000004680 |
| Drug | choline | MARS1 ECD HEPH CHPT1 PLCB1 PLA2G4A PLCB3 PLCB4 PLP1 GPLD1 PLCZ1 MGAM FMO1 FMO3 PDPR ABCG1 PNPLA8 | 5.77e-07 | 320 | 282 | 17 | CID000000305 |
| Drug | felodipine | CYP1B1 MYLK CYP2F1 PDE6B CYP2S1 RYR1 RYR2 CACNA1I CACNA1D CACNA2D4 CATSPER1 PDE7B | 1.40e-06 | 169 | 282 | 12 | CID000003333 |
| Drug | CNS 1145 | 2.86e-06 | 33 | 282 | 6 | CID000190902 | |
| Drug | IHC-64 | 2.86e-06 | 33 | 282 | 6 | CID000162753 | |
| Drug | lindane | MARS1 RYR1 RYR2 TWIST1 RASIP1 PLCB1 SERINC3 PLCB3 PLCB4 CACNA1D PLCZ1 | 3.64e-06 | 154 | 282 | 11 | CID000000727 |
| Drug | BAPTA-AM | MYLK RYR1 MYLK3 PIK3C2G PLCB1 PLCB3 PLCB4 GPLD1 CACNA1D PLCZ1 ANXA6 CACNA2D4 CATSPER1 AIFM1 LRP6 | 4.22e-06 | 293 | 282 | 15 | CID000002293 |
| Drug | hydroxyl radicals | CMBL TPO CYP1B1 PDE6A CYP2F1 PDE6B MARS1 CYP2S1 USP20 RASIP1 FASN PTPN9 GANAB PTPRG PLCB1 PLA2G4A PLCB3 PLCB4 PLA2G7 GPLD1 PLCZ1 MGAM FMO1 FMO2 FMO3 PDPR PTPRU PIGU ATP8B2 PPM1G LPL LPO TM7SF2 LRP6 PNPLA8 PDE7B ATP4B | 4.26e-06 | 1341 | 282 | 37 | CID000000961 |
| Drug | AC1L1KS5 | RYR1 RYR2 PIK3C2G PLCB1 PLA2G4A CACNA1I PLCB3 PLCB4 NMBR GPLD1 CACNA1D PLCZ1 CACNA2D4 CATSPER1 TIAM1 LPL | 4.72e-06 | 334 | 282 | 16 | CID000005631 |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | NCAPH2 CUL7 RASIP1 PLCB1 CACNA1I GPLD1 ARHGEF12 ADAMTS13 APP ECPAS CNTNAP2 EPHB1 | 6.85e-06 | 197 | 282 | 12 | 5207_UP |
| Drug | POPC | SPTAN1 FASN PIK3C2G PLCB1 PLA2G4A PLCB3 PLCB4 PLP1 PLA2G7 GPLD1 PLCZ1 ANXA6 ABCG1 LPL PNPLA8 | 7.13e-06 | 306 | 282 | 15 | CID000065167 |
| Drug | Benzydamine | 7.45e-06 | 4 | 282 | 3 | ctd:D001591 | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | TSNAXIP1 PDE6B RAD54L2 USP20 PLCB1 NSD1 GRIK5 PTPRU ECPAS AP4E1 LRP6 THNSL2 | 7.60e-06 | 199 | 282 | 12 | 2243_DN |
| Drug | gamma-aminobutyric acid | XIRP1 MARS1 RYR1 RYR2 TWIST1 CLCN4 KCNC2 SV2A CACNA1I TDRD6 CACNA1D CLIC4 GPRC6A GRIK5 CLIC6 OPRK1 CRYGD CACNA2D4 CATSPER1 | 8.11e-06 | 474 | 282 | 19 | CID000000119 |
| Drug | genistein | EPHB4 NAT1 CYP1B1 ERBB3 MYLK PDE6B GADD45A USP20 RYR1 RYR2 TWIST1 JAK1 CLCN4 PIK3C2G CLPTM1 PLCB1 PLA2G4A CACNA1I PLCB3 FGFR1 PLCB4 SEC61A1 GPLD1 CACNA1D PLCZ1 LAMA3 LAMA5 CLIC4 CLIC6 CACNA2D4 CATSPER1 LPL | 9.51e-06 | 1117 | 282 | 32 | CID005280961 |
| Drug | glycerol-3-phosphocholine | PDE6A PDE6B PLCB1 PLA2G4A PLCB3 PLCB4 PLA2G7 GPLD1 PLCZ1 MGAM PDE7B | 1.05e-05 | 172 | 282 | 11 | CID000000823 |
| Drug | isovalerate | MGAT4A RYR1 PLA2G4A CACNA1I CACNA1D CRYGC CACNA2D4 CATSPER1 PNPLA8 SUFU | 1.22e-05 | 143 | 282 | 10 | CID000010430 |
| Drug | balofloxacin | 1.23e-05 | 42 | 282 | 6 | CID000065958 | |
| Drug | lercanidipine | 1.27e-05 | 63 | 282 | 7 | CID000065866 | |
| Drug | AC1L1K7T | NAT1 CYP1B1 ERBB3 CYP2F1 DHX38 FASN CLCN4 CLU PIK3C2G PLCB1 PLCB3 FGFR1 PLCB4 GPLD1 PLCZ1 FMO1 FMO3 TCN1 CLIC4 CLIC6 LDLR LPL | 1.45e-05 | 632 | 282 | 22 | CID000005376 |
| Drug | thiobenzamide | 1.50e-05 | 26 | 282 | 5 | CID000683563 | |
| Drug | perchlorate | 1.62e-05 | 90 | 282 | 8 | CID000024247 | |
| Drug | Ccris 2188 | 1.85e-05 | 5 | 282 | 3 | CID000146896 | |
| Drug | gallopamil | 1.91e-05 | 67 | 282 | 7 | CID000001234 | |
| Drug | methyl p-tolyl sulfide | 2.09e-05 | 14 | 282 | 4 | CID000069334 | |
| Drug | AC1L2AC7 | 2.32e-05 | 69 | 282 | 7 | CID000068733 | |
| Drug | FPL 64176 | 2.82e-05 | 15 | 282 | 4 | CID000003423 | |
| Drug | aminostimil | 2.82e-05 | 15 | 282 | 4 | CID000021450 | |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; MCF7; HT_HG-U133A | CYP1B1 TBC1D5 SPTAN1 NCAPH2 RAD54L2 USP20 PLCB1 TTC38 ARHGEF12 ATP8B2 CRKL | 3.07e-05 | 193 | 282 | 11 | 7341_UP |
| Drug | (2S,3R)-Sphingosine | ERBB3 MYLK ECD RYR1 RYR2 PLCB1 PLA2G4A PLCB3 TRPM1 PLCB4 SDK1 PMM1 PLA2G7 GPLD1 PLCZ1 TIAM1 | 3.11e-05 | 389 | 282 | 16 | CID000001104 |
| Drug | AC1Q6T8I | 3.11e-05 | 30 | 282 | 5 | CID000000343 | |
| Drug | dapsone | 3.37e-05 | 73 | 282 | 7 | CID000002955 | |
| Drug | xanthate | 3.44e-05 | 50 | 282 | 6 | CID000008823 | |
| Drug | C10A | 3.66e-05 | 6 | 282 | 3 | CID000041624 | |
| Drug | SKF83742 | 3.66e-05 | 6 | 282 | 3 | CID000130828 | |
| Drug | terbufos | DCC GADD45A RYR2 TWIST1 GJA4 CLCN4 MYOZ1 PTPRG SV2B SV2A CRYBG1 NMBR PLA2G7 CLIC6 APP ESYT3 ST6GALNAC5 CNTNAP2 HHIPL1 SLC2A13 PAX7 SLC5A8 LARGE1 | 3.88e-05 | 724 | 282 | 23 | ctd:C012568 |
| Drug | genistein; Down 200; 10uM; PC3; HT_HG-U133A | CYP1B1 SPTAN1 DHX38 ACTN4 VAV3 FGFR1 DOCK10 APP ATP8B2 CNTNAP2 WDFY3 | 3.88e-05 | 198 | 282 | 11 | 1235_DN |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; HL60; HT_HG-U133A | SPTAN1 NXPE3 SV2A SHPK FGFR1 PLP1 PLA2G7 APP ATP8B2 LRP6 LARGE1 | 3.88e-05 | 198 | 282 | 11 | 2191_DN |
| Drug | Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | CYP1B1 MARS1 RYR2 CLCN4 SV2A NMBR TTC38 DOCK10 CRKL DEPDC5 PAX3 | 4.07e-05 | 199 | 282 | 11 | 6092_UP |
| Drug | cadmium | CMBL CYP1B1 MARS1 RYR1 PRTFDC1 PLCB1 CACNA1I FGFR1 GPLD1 CACNA1D MGAM LARS1 APP CACNA2D4 CATSPER1 AIFM1 LRP6 | 4.22e-05 | 443 | 282 | 17 | CID000002514 |
| Drug | N-ethyl-N-nitrosourea | ERBB3 AMER1 PDE6A PDE6B NCAPH2 FES HERC1 AHCTF1 CRYGA CRYGB CRYGC CRYGD SMARCA2 | 4.24e-05 | 275 | 282 | 13 | CID000012967 |
| Drug | bityrosine | 4.76e-05 | 77 | 282 | 7 | CID000107904 | |
| Drug | loperamide | 4.95e-05 | 105 | 282 | 8 | CID000003954 | |
| Drug | AC1L1KC5 | ERBB3 MYLK NAIP RYR1 RYR2 MYLK3 CLU PIK3C2G PLCB1 PLA2G4A CACNA1I PLCB3 PLCB4 NMBR GPLD1 CACNA1D CACNA2D4 UBXN11 CATSPER1 | 4.99e-05 | 541 | 282 | 19 | CID000005428 |
| Drug | mercury | MARS1 HEPH RYR1 RYR2 SPG21 PIK3C2G CLPTM1 BUB1 FES PLCB1 CACNA1I PMM1 CACNA1D MGAM DOCK10 SLC13A3 ABCG1 CACNA2D4 CATSPER1 | 5.11e-05 | 542 | 282 | 19 | CID000023931 |
| Drug | AC1L1KRB | 5.37e-05 | 54 | 282 | 6 | CID000005621 | |
| Drug | Fura-2AM | 5.62e-05 | 79 | 282 | 7 | CID000105091 | |
| Drug | aminopyrine | 5.67e-05 | 171 | 282 | 10 | CID000006009 | |
| Drug | alpha-methylhomocysteine-thiolactone | 5.96e-05 | 55 | 282 | 6 | CID000133014 | |
| Drug | Cinildipine | 6.61e-05 | 56 | 282 | 6 | CID000002752 | |
| Drug | ST271 | 6.74e-05 | 35 | 282 | 5 | CID006439072 | |
| Drug | myo-inositol | ERBB3 MYLK RYR1 RYR2 CHPT1 AP2B1 PIK3C2G PLCB1 CACNA1I PLCB3 FGFR1 PLCB4 NMBR VAV1 GPLD1 CACNA1D PLCZ1 GPRC6A TEC CRKL CACNA2D4 CATSPER1 LPL SLC2A13 | 7.97e-05 | 811 | 282 | 24 | CID000000892 |
| Drug | mag-fura-2 | 8.86e-05 | 37 | 282 | 5 | CID000123839 | |
| Drug | Fonofos | DCC RYR2 TWIST1 GJA4 CLCN4 MYOZ1 PTPRG SV2B SV2A CRYBG1 NMBR PLA2G7 CLIC6 APP ESYT3 ST6GALNAC5 CNTNAP2 HHIPL1 SLC2A13 PAX7 SLC5A8 LARGE1 | 8.93e-05 | 714 | 282 | 22 | ctd:D004397 |
| Drug | nilvadipine | 9.78e-05 | 60 | 282 | 6 | CID000004494 | |
| Drug | Sulcrate | 9.87e-05 | 148 | 282 | 9 | CID006398525 | |
| Drug | S-[2-[3-[[(2R)-4-[[[(2R,3R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (3S)-3-hydroxy-3-methyl-5-oxohexanethioate | 1.01e-04 | 8 | 282 | 3 | CID016061173 | |
| Drug | 1,5-benzothiazepin-4(5H)-one | 1.01e-04 | 8 | 282 | 3 | CID000358939 | |
| Drug | AC1NBU2S | 1.07e-04 | 117 | 282 | 8 | CID004473765 | |
| Drug | IAA-94 | 1.07e-04 | 61 | 282 | 6 | CID000003667 | |
| Drug | AC1L1CR9 | 1.17e-04 | 21 | 282 | 4 | CID000002023 | |
| Drug | Ibuprofen | CMBL GBE1 DDX1 FASN CHPT1 CLU SEC61A1 ANKRD13D DPH1 LARS1 LAMA3 APP LDLR ABCG1 LPL SLC5A8 | 1.22e-04 | 437 | 282 | 16 | ctd:D007052 |
| Drug | dicyclohexyl phthalate | EPHB4 CYP1B1 ERBB3 ACTN4 GADD45A AP2B1 SERINC3 GPLD1 MGAM FMO1 FMO3 ANXA6 ARHGEF12 LAMA3 PTPRU OPRK1 ARHGAP5 CRYGB TIAM1 MTHFR LPL PAX3 SLC5A8 HAS1 | 1.27e-04 | 836 | 282 | 24 | ctd:C036042 |
| Drug | ET-18-OCH3 | 1.27e-04 | 120 | 282 | 8 | CID000001392 | |
| Drug | vanadyl | ERBB3 PDE6B JAK1 PTPRG PIK3C2G FES DNAH9 VAV1 GPLD1 MGAM CRKL LRP6 PDE7B | 1.29e-04 | 307 | 282 | 13 | CID000061671 |
| Drug | 5-amidinobenzimidazole | 1.34e-04 | 154 | 282 | 9 | CID000001800 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.40e-04 | 155 | 282 | 9 | 6817_DN | |
| Drug | AC1NUW81 | 1.41e-04 | 22 | 282 | 4 | CID005462220 | |
| Drug | baclofen | RYR1 RYR2 TWIST1 CACNA1I CACNA1D GPRC6A OPRK1 CRYGD CACNA2D4 CATSPER1 | 1.42e-04 | 191 | 282 | 10 | CID000002284 |
| Drug | carbachol | ERBB3 MYLK RYR1 RYR2 PIK3C2G PLCB1 CACNA1I PLCB3 PLCB4 NMBR PLA2G7 GPLD1 CACNA1D PLCZ1 LAMA3 LAMA5 APP CACNA2D4 UBXN11 CATSPER1 LPL | 1.47e-04 | 688 | 282 | 21 | CID000002551 |
| Drug | TCVC | 1.49e-04 | 9 | 282 | 3 | CID000108091 | |
| Drug | Clorocruoro Hem | 1.51e-04 | 123 | 282 | 8 | CID003518809 | |
| Drug | 1,3-dimethyl-benzimidazole-2-thione | 1.53e-04 | 2 | 282 | 2 | CID000123191 | |
| Drug | asterinic acid | 1.53e-04 | 2 | 282 | 2 | CID006443726 | |
| Drug | 7,8,7',8'-tetradehydroastaxanthin | 1.53e-04 | 2 | 282 | 2 | CID012299845 | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | PDE6B RYR2 HOXB7 CACNA1I TTC38 GPLD1 HCN4 ABCG1 MTHFR DEPDC5 | 1.55e-04 | 193 | 282 | 10 | 4380_DN |
| Drug | halothane | CYP1B1 CYP2F1 CYP2S1 RYR1 RYR2 PLCB1 CACNA1I PLCB3 PLCB4 CACNA1D PLCZ1 CACNA2D4 CATSPER1 | 1.61e-04 | 314 | 282 | 13 | CID000003562 |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | MYLK TBC1D5 RAD54L2 USP20 GJA4 BUB1 CACNA1I DOCK10 CRYGD MTHFR | 1.61e-04 | 194 | 282 | 10 | 4110_UP |
| Drug | AC1L1GTT | MYLK RYR1 RYR2 MYLK3 PLA2G4A PLCB3 CACNA1D SLC13A3 CRYGD CACNA2D4 TIAM1 | 1.66e-04 | 233 | 282 | 11 | CID000003837 |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.68e-04 | 195 | 282 | 10 | 6654_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | TSNAXIP1 SPTAN1 CACNA1I FGFR1 HCN4 APP MTHFR TNK2 WDFY3 DOP1A | 1.68e-04 | 195 | 282 | 10 | 4373_DN |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | TSNAXIP1 CYP1B1 PDE6B MGAT4A RYR2 AP2B1 PLCB1 VAV3 MTHFR CNTNAP2 | 1.68e-04 | 195 | 282 | 10 | 4676_DN |
| Drug | glutamate | MYLK MARS1 RYR1 RYR2 CLCN4 SV2A PLCB1 CACNA1I PLCB3 TRPM1 PLCB4 TAF1 GPLD1 CACNA1D PLCZ1 LARS1 CLIC4 SLC13A3 GPRC6A GRIK5 CLIC6 OPRK1 CRYGD CACNA2D4 CATSPER1 AIFM1 | 1.73e-04 | 962 | 282 | 26 | CID000000611 |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; HL60; HT_HG-U133A | TSNAXIP1 SPTAN1 RAD54L2 USP20 RYR1 SLC23A2 HCN4 SLC13A3 GRIK5 TNK2 | 1.75e-04 | 196 | 282 | 10 | 2951_UP |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A | PDE6B NCAPH2 RAD54L2 USP20 MYOZ1 PLCB1 CACNA1I TTC38 ARHGEF12 LRP6 | 1.75e-04 | 196 | 282 | 10 | 2232_DN |
| Drug | bepridil | 1.78e-04 | 126 | 282 | 8 | CID000002351 | |
| Drug | methimazole | 1.78e-04 | 126 | 282 | 8 | CID001349907 | |
| Drug | manidipine | 1.81e-04 | 95 | 282 | 7 | CID000004008 | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A | RAD54L2 CUL7 PLCB1 TAF1 TTC38 MAP3K14 LAMA3 PTPRU AP4E1 WDFY3 | 1.83e-04 | 197 | 282 | 10 | 5449_DN |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | TSNAXIP1 CYP1B1 NCAPH2 NXPE3 CNTN1 RPGRIP1L PTPRU ECPAS AP4E1 WDFY3 | 1.83e-04 | 197 | 282 | 10 | 3292_UP |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | TSNAXIP1 SPTAN1 BUB1 FES TTC38 VAV1 CNTN1 SP110 CRYGB CNTNAP2 | 1.83e-04 | 197 | 282 | 10 | 5741_UP |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | CYP1B1 NAA80 RAD54L2 CUL7 NMBR SLC23A2 GPLD1 CACNA1D OPRK1 AP4E1 | 1.83e-04 | 197 | 282 | 10 | 6009_UP |
| Drug | He I | 1.84e-04 | 43 | 282 | 5 | CID000094789 | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; PC3; HT_HG-U133A | TBC1D5 NCAPH2 RAD54L2 NXPE3 CLCN4 HCN4 SEC61A2 CRYGC ABCG1 TIAM1 | 1.90e-04 | 198 | 282 | 10 | 6289_UP |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; PC3; HT_HG-U133A | LGALS14 CUL7 ABCG4 FGFR1 GPLD1 FSCN3 GRIK5 SP110 MTHFR EPHB1 | 1.98e-04 | 199 | 282 | 10 | 6660_UP |
| Drug | Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; PC3; HT_HG-U133A | NCAPH2 RAD54L2 BUB1 PLCB3 FGFR1 TAF1 SLC23A2 GPLD1 ADAMTS13 AP4E1 | 1.98e-04 | 199 | 282 | 10 | 6307_UP |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | RAD54L2 NXPE3 CLPTM1 PLCB1 TTC38 FSCN3 GRIK5 SMARCA2 WDFY3 THNSL2 | 1.98e-04 | 199 | 282 | 10 | 5201_UP |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; HL60; HT_HG-U133A | ABCG4 PLCB3 CNTN1 TCN1 CNTNAP1 APP CRYGD ABCG1 SLC16A5 EPHB1 | 1.98e-04 | 199 | 282 | 10 | 2198_UP |
| Drug | Pregnenolone [145-13-1]; Up 200; 12.6uM; HL60; HT_HG-U133A | HEPH CLCN4 PLCB1 CACNA1I GRIK5 ABCG1 SLC16A5 MTHFR LRP6 THNSL2 | 1.98e-04 | 199 | 282 | 10 | 2497_UP |
| Disease | pulse pressure measurement | EPHB4 TDRD15 SYNPO2L ACTN4 TWIST1 HOXA7 HOXB7 FASN TTBK1 PRPF40B RPTOR EDARADD FES KLHL42 CLEC16A CACNA1D PDPR WDR7 ARHGEF12 LAMA5 TEC TBX18 FAM171A2 MTHFR LPL CPXM1 REG3A HHIPL1 SLC2A13 SUFU TEC | 6.15e-06 | 1392 | 273 | 31 | EFO_0005763 |
| Disease | inferior parietal cortex volume measurement | 2.49e-05 | 19 | 273 | 4 | EFO_0010307 | |
| Disease | Gastric Adenocarcinoma | 5.90e-05 | 45 | 273 | 5 | C0278701 | |
| Disease | Cataract microcornea syndrome | 6.31e-05 | 9 | 273 | 3 | C1861829 | |
| Disease | neural tube defect (implicated_via_orthology) | 6.31e-05 | 9 | 273 | 3 | DOID:0080074 (implicated_via_orthology) | |
| Disease | Stuttering, Familial Persistent 1 | 8.53e-05 | 2 | 273 | 2 | C3489627 | |
| Disease | Infantile liver failure | 8.53e-05 | 2 | 273 | 2 | cv:C5681094 | |
| Disease | cataract 2 multiple types (implicated_via_orthology) | 8.53e-05 | 2 | 273 | 2 | DOID:0110235 (implicated_via_orthology) | |
| Disease | Multiminicore myopathy | 8.53e-05 | 2 | 273 | 2 | cv:C0270962 | |
| Disease | triglyceride change measurement, low density lipoprotein cholesterol measurement | 8.53e-05 | 2 | 273 | 2 | EFO_0004611, EFO_0007681 | |
| Disease | platelet component distribution width | EPHB4 TBC1D5 GADD45A DCAF5 PRTFDC1 FAM187B AP2B1 PLCB1 CAMTA1 HERC1 VAV1 CFAP73 DOCK10 LAMA5 CLIC4 CRKL MEIOC LPL TNXB | 8.84e-05 | 755 | 273 | 19 | EFO_0007984 |
| Disease | Antithrombotic agent use measurement | 1.56e-04 | 55 | 273 | 5 | EFO_0009925 | |
| Disease | Oligodontia | 1.62e-04 | 12 | 273 | 3 | C4082304 | |
| Disease | Congenital muscular dystrophy | 1.62e-04 | 12 | 273 | 3 | cv:C0699743 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.85e-04 | 31 | 273 | 4 | C1335167 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ERBB3 TBC1D5 GBE1 DCC TMEM132B RYR2 MRPS30 KCNC2 PRPF40B ERAP2 FGFR1 CAMTA1 HERC1 SDK1 CACNA1D CPXM2 DOCK10 HPS5 EPHB1 | 1.89e-04 | 801 | 273 | 19 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | RHABDOMYOSARCOMA 2 | 2.54e-04 | 3 | 273 | 2 | 268220 | |
| Disease | Alveolar rhabdomyosarcoma | 2.54e-04 | 3 | 273 | 2 | cv:C0206655 | |
| Disease | acrocephalosyndactylia (is_implicated_in) | 2.54e-04 | 3 | 273 | 2 | DOID:12960 (is_implicated_in) | |
| Disease | Pfeiffer Syndrome | 2.54e-04 | 3 | 273 | 2 | C0220658 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.54e-04 | 3 | 273 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | alveolar rhabdomyosarcoma (is_implicated_in) | 2.54e-04 | 3 | 273 | 2 | DOID:4051 (is_implicated_in) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.54e-04 | 3 | 273 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Spinal Cord Diseases | 2.54e-04 | 3 | 273 | 2 | C0037928 | |
| Disease | Hypodontia | 2.64e-04 | 14 | 273 | 3 | C0020608 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 3.24e-04 | 99 | 273 | 6 | DOID:11446 (biomarker_via_orthology) | |
| Disease | vision disorder | 4.01e-04 | 16 | 273 | 3 | MONDO_0021084 | |
| Disease | atherosclerosis (is_implicated_in) | 4.01e-04 | 16 | 273 | 3 | DOID:1936 (is_implicated_in) | |
| Disease | aspirin use measurement | 4.57e-04 | 39 | 273 | 4 | EFO_0007013 | |
| Disease | Night blindness, congenital stationary | 4.84e-04 | 17 | 273 | 3 | C0339535 | |
| Disease | visceral:subcutaneous adipose tissue ratio | 4.84e-04 | 70 | 273 | 5 | EFO_0004767 | |
| Disease | glycosyltransferase-like protein LARGE1 measurement | 5.05e-04 | 4 | 273 | 2 | EFO_0802578 | |
| Disease | Rare disease with malignant hyperthermia | 5.05e-04 | 4 | 273 | 2 | cv:C5681128 | |
| Disease | tyrosine-protein kinase TEC measurement | 5.05e-04 | 4 | 273 | 2 | EFO_0020830 | |
| Disease | TWIST1-related craniosynostosis | 5.05e-04 | 4 | 273 | 2 | cv:C4551902 | |
| Disease | CATARACT, AUTOSOMAL DOMINANT | 5.05e-04 | 4 | 273 | 2 | C1858679 | |
| Disease | tenascin-X measurement | 5.05e-04 | 4 | 273 | 2 | EFO_0802121 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 5.77e-04 | 18 | 273 | 3 | DOID:0080208 (is_implicated_in) | |
| Disease | alcohol consumption measurement | GBE1 DCC RASIP1 KCNC2 RPTOR PKHD1 PLCB1 CACNA1I PLCB3 WDR90 CAMTA1 CLEC16A SDK1 PMM1 CACNA1D MGAM GPRC6A GRIK5 CLIC6 SELENON PPM1G ST6GALNAC5 SLC2A13 SUFU | 5.83e-04 | 1242 | 273 | 24 | EFO_0007878 |
| Disease | hypertension | HOXB7 TTBK1 RPTOR FES PLCB3 CACNA1D ARHGEF12 TIAM1 MTHFR TNXB | 6.24e-04 | 307 | 273 | 10 | EFO_0000537 |
| Disease | Schizophrenia | ERBB3 DCC IL18R1 TXNDC5 CLU SV2A PLCB1 PLA2G4A TRPM1 FGFR1 PLP1 GRIK5 MTHFR LPL CNTNAP2 SMARCA2 PDE7B TNXB B3GAT2 | 6.25e-04 | 883 | 273 | 19 | C0036341 |
| Disease | cholesterol to total lipids in large VLDL percentage | 7.93e-04 | 45 | 273 | 4 | EFO_0022236 | |
| Disease | 2-hydroxy-4-(methylthio)butanoic acid measurement | 8.37e-04 | 5 | 273 | 2 | EFO_0800113 | |
| Disease | Alveolar rhabdomyosarcoma | 8.37e-04 | 5 | 273 | 2 | C0206655 | |
| Disease | pulmonary alveolar proteinosis (implicated_via_orthology) | 8.37e-04 | 5 | 273 | 2 | DOID:12120 (implicated_via_orthology) | |
| Disease | immature platelet measurement | 8.61e-04 | 119 | 273 | 6 | EFO_0803541 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 8.92e-04 | 80 | 273 | 5 | DOID:6432 (biomarker_via_orthology) | |
| Disease | free cholesterol in very small VLDL measurement | 9.35e-04 | 47 | 273 | 4 | EFO_0022275 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 1.01e-03 | 48 | 273 | 4 | C1862941 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 1.01e-03 | 48 | 273 | 4 | C4551993 | |
| Disease | angina pectoris | 1.11e-03 | 125 | 273 | 6 | EFO_0003913 | |
| Disease | response to anticonvulsant | 1.17e-03 | 85 | 273 | 5 | GO_0036277 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1.18e-03 | 50 | 273 | 4 | C1862939 | |
| Disease | Congenital myopathy with fiber type disproportion | 1.25e-03 | 6 | 273 | 2 | cv:C0546264 | |
| Disease | retinal disease (implicated_via_orthology) | 1.25e-03 | 6 | 273 | 2 | DOID:5679 (implicated_via_orthology) | |
| Disease | 2-hydroxy-3-methylvalerate measurement | 1.25e-03 | 6 | 273 | 2 | EFO_0800027 | |
| Disease | serum amyloid A protein measurement | 1.25e-03 | 6 | 273 | 2 | EFO_0004728 | |
| Disease | Sick Sinus Syndrome | 1.25e-03 | 6 | 273 | 2 | C0037052 | |
| Disease | alkaline phosphatase measurement, liver enzyme measurement | 1.25e-03 | 6 | 273 | 2 | EFO_0004533, EFO_0004582 | |
| Disease | muscular disease (is_implicated_in) | 1.25e-03 | 6 | 273 | 2 | DOID:0080000 (is_implicated_in) | |
| Disease | smoking status measurement | ERBB3 TBC1D5 GBE1 DCC TMEM132B DCAF5 RYR2 PTPRG KCNC2 BYSL PKHD1 FGFR1 CAMTA1 HERC1 SDK1 CNTN1 CACNA1D CPXM2 GRIK5 PIGU CNTNAP2 EPHB1 | 1.25e-03 | 1160 | 273 | 22 | EFO_0006527 |
| Disease | Coronary heart disease | 1.37e-03 | 24 | 273 | 3 | C0010068 | |
| Disease | phosphatidylcholine measurement | 1.40e-03 | 284 | 273 | 9 | EFO_0010226 | |
| Disease | Necrosis | 1.69e-03 | 55 | 273 | 4 | C0027540 | |
| Disease | Nasal Cavity Polyp | 1.69e-03 | 55 | 273 | 4 | EFO_1000391 | |
| Disease | Craniosynostosis syndrome | 1.74e-03 | 7 | 273 | 2 | cv:C0010278 | |
| Disease | alpha-hydroxyisovalerate measurement | 1.74e-03 | 7 | 273 | 2 | EFO_0800023 | |
| Disease | myeloid neoplasm (is_implicated_in) | 1.74e-03 | 7 | 273 | 2 | DOID:0070004 (is_implicated_in) | |
| Disease | atherosclerosis (implicated_via_orthology) | 1.74e-03 | 7 | 273 | 2 | DOID:1936 (implicated_via_orthology) | |
| Disease | smoking behaviour measurement, body mass index | 1.74e-03 | 7 | 273 | 2 | EFO_0004340, EFO_0005671 | |
| Disease | Depressive Symptoms | 1.74e-03 | 26 | 273 | 3 | C0086132 | |
| Disease | Malignant neoplasm of prostate | NAT1 CYP1B1 ERBB3 GADD45A ELAC2 JAK1 TXNDC5 CLU SERINC3 VAV3 CLIC4 MTHFR LPL ADI1 | 1.94e-03 | 616 | 273 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | NAT1 CYP1B1 ERBB3 GADD45A ELAC2 JAK1 TXNDC5 CLU SERINC3 VAV3 CLIC4 MTHFR LPL ADI1 | 1.94e-03 | 616 | 273 | 14 | C0033578 |
| Disease | upper aerodigestive tract neoplasm | 2.17e-03 | 246 | 273 | 8 | EFO_0004284 | |
| Disease | Scoliosis, unspecified | 2.30e-03 | 8 | 273 | 2 | C0036439 | |
| Disease | Hyperlipoproteinemia | 2.30e-03 | 8 | 273 | 2 | cv:C0020476 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.30e-03 | 8 | 273 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | 1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1) measurement | 2.30e-03 | 8 | 273 | 2 | EFO_0800420 | |
| Disease | 1,5 anhydroglucitol measurement | 2.40e-03 | 29 | 273 | 3 | EFO_0008009 | |
| Disease | coronary artery disease (is_implicated_in) | 2.41e-03 | 100 | 273 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | EPHB4 CYP1B1 ERBB3 XIRP1 ABCA3 SPTAN1 SORCS1 FASN PLCB1 PLA2G4A UTP20 FGFR1 NMBR DNAH9 PANX2 HELQ SP110 ZNF546 MTHFR DOP1A | 2.54e-03 | 1074 | 273 | 20 | C0006142 |
| Disease | mean arterial pressure | SYNPO2L HOXB7 TTBK1 ERAP2 RPTOR FES PKHD1 CACNA1D WDR7 DOCK10 ARHGEF12 MTHFR | 2.54e-03 | 499 | 273 | 12 | EFO_0006340 |
| Disease | Weight Gain | 2.62e-03 | 102 | 273 | 5 | C0043094 | |
| Disease | lysophosphatidylcholine measurement | 2.62e-03 | 62 | 273 | 4 | EFO_0010224 | |
| Disease | velocardiofacial syndrome (implicated_via_orthology) | 2.94e-03 | 9 | 273 | 2 | DOID:12583 (implicated_via_orthology) | |
| Disease | Mental deterioration | 2.94e-03 | 9 | 273 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 2.94e-03 | 9 | 273 | 2 | C1270972 | |
| Disease | CATARACT, COPPOCK-LIKE | 2.94e-03 | 9 | 273 | 2 | C1852438 | |
| Disease | interleukin 18 receptor accessory protein measurement | 2.94e-03 | 9 | 273 | 2 | EFO_0008179 | |
| Disease | retinal detachment (biomarker_via_orthology) | 2.94e-03 | 9 | 273 | 2 | DOID:5327 (biomarker_via_orthology) | |
| Disease | Cataract, Pulverulent | 2.94e-03 | 9 | 273 | 2 | C1833118 | |
| Disease | familial hyperlipidemia | 3.10e-03 | 106 | 273 | 5 | MONDO_0001336 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 3.12e-03 | 65 | 273 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | vitamin B12 measurement | 3.19e-03 | 32 | 273 | 3 | EFO_0004620 | |
| Disease | asthma, seasonal allergic rhinitis | 3.19e-03 | 32 | 273 | 3 | EFO_0003956, MONDO_0004979 | |
| Disease | mean platelet volume | DOCK11 TBC1D5 ACTN4 GADD45A DCAF5 RASIP1 FAM187B AP2B1 PLCB1 CAMTA1 VAV1 FERMT3 DOCK10 CLIC4 PRRT2 CRKL MEIOC MTHFR LPL | 3.23e-03 | 1020 | 273 | 19 | EFO_0004584 |
| Disease | retinal degeneration (implicated_via_orthology) | 3.48e-03 | 33 | 273 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | HOMA-IR | 3.48e-03 | 33 | 273 | 3 | EFO_0004501 | |
| Disease | prostate cancer (implicated_via_orthology) | 3.48e-03 | 33 | 273 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | reaction time measurement | SLC39A11 GBE1 ACTN4 DCC KCNC2 PKHD1 CAMTA1 CNTN1 DXO WDR7 CEP192 PTPRU CACNA2D4 CDH7 | 3.51e-03 | 658 | 273 | 14 | EFO_0008393 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYWPSREESMNCEAF | 1261 | P23470 | |
| DMQRRASPDLSTGYW | 976 | Q13075 | |
| VDAGFGRSYQMWQPL | 121 | P18440 | |
| VWELMTFGAEPYAGL | 901 | P21860 | |
| TWNEVFEFMVYEVPG | 356 | A0FGR9 | |
| YWMTGQPAETSRFLL | 491 | Q9H172 | |
| LFPNISAEDMELRWY | 56 | A8MVZ5 | |
| RNFDIPKEMTGIWRY | 206 | Q9Y696 | |
| QSGRVFMVTDYSPEW | 866 | Q9Y6Y1 | |
| MERPFLGAIQYWNAS | 641 | P78357 | |
| GFFEPGTWMRYNLQS | 1001 | P78357 | |
| WNPADRDNAIGFYMA | 421 | Q8IUX8 | |
| GAAPQRANMESWREY | 136 | Q4G0S4 | |
| RQAPDFYVEMKWEFT | 116 | Q6ZTN6 | |
| EPDARAAMIWIVGEY | 441 | P63010 | |
| ANPWEFYIGTQLMER | 826 | O43683 | |
| AYQLSNGIPIESWFM | 411 | Q05D32 | |
| YMDSRAQGAWYIIPI | 636 | Q8NEC5 | |
| VYWMTSQPSDAVRFV | 521 | P45844 | |
| ETGPCRAMISRWYFD | 296 | P05067 | |
| WERALTPDEIAMYFT | 231 | Q6QNK2 | |
| MFWSDLGPDVGYEAI | 481 | O95831 | |
| GYRSNTFFWIPMAAS | 1021 | Q8IUA7 | |
| LEYAKRAAPFNNWME | 531 | O43707 | |
| YPFDMTRTPWAAREL | 506 | Q96SM3 | |
| VTWYMEAVFPGQFGV | 466 | Q99758 | |
| GIWPRQSTYMDRVFK | 381 | Q8WU67 | |
| LEYLWETAQMYPRPN | 406 | Q5JTC6 | |
| IRVDSGCWMLYERPN | 36 | P11844 | |
| MYRWAFIPEASDDSG | 2321 | Q5JWR5 | |
| DRPAGVGVYTAMWQL | 431 | P51793 | |
| REFYDPDTVELMNWI | 551 | Q6ZPD9 | |
| EYWCMVDFVRPDFLG | 501 | Q9Y4B4 | |
| MAVPWEEYFRLALQE | 1 | A6NFT4 | |
| KYRDFEFPSEMTGIW | 656 | Q96NY7 | |
| EFPSEMTGIWRYLNN | 661 | Q96NY7 | |
| ALRDISWQQPYPMDF | 371 | Q9BZG8 | |
| GQRMEEFQRYCWNPD | 11 | P51164 | |
| YFQLSVDWPESSLAM | 366 | O95905 | |
| YRECDMQLFGPWGEI | 1296 | Q76LX8 | |
| FGVTLWEMFTYGQEP | 316 | Q07912 | |
| TPEFLVQQRWGAMEY | 1471 | Q9NZN5 | |
| FFPEAAQVAYQMWEL | 331 | P08133 | |
| YPQRFLQVMSWVLGE | 506 | Q9UPM8 | |
| IWEHEVGMRFQVYLP | 316 | P98198 | |
| VGMRFQVYLPWDEAV | 321 | P98198 | |
| MVARYIRINPQSWFD | 266 | Q8N436 | |
| SLMERGQGRPFYQWS | 786 | Q5U651 | |
| WFGDVEAETMYRSPR | 416 | Q9UBG7 | |
| WTHQARVFPYMEGDV | 1806 | Q96L73 | |
| VIMDDWPGYDLNLFT | 16 | Q9NRG1 | |
| WDMFATPQYRGVRAG | 266 | Q86V24 | |
| RMYANLVTGECVWDP | 41 | Q9C0H5 | |
| FQIMSSPWGELYDIF | 206 | P24903 | |
| RDSPVFWYAPECLMQ | 1041 | P23458 | |
| VTLQIDFPATGWEYM | 621 | O75747 | |
| QGPLENTYRDFWLMV | 376 | P43378 | |
| YKRENPGMFSWEIRD | 121 | P23759 | |
| SFQLISEPMFGDYWI | 166 | Q6IE37 | |
| SEPMFGDYWIVVKRN | 171 | Q6IE37 | |
| PEEEDQYWLSMGRTF | 846 | O75140 | |
| EVMSFGERPYWDMSN | 816 | P54762 | |
| TYMGEDFFWAITPIA | 411 | Q9UM21 | |
| METLEPNNLWYLFTG | 671 | P43146 | |
| DRMAAGGPLYIDVTW | 81 | P42898 | |
| WPVELNDTGSYFFQM | 86 | Q13478 | |
| LQPRMWALFEDPYSS | 211 | Q96PR1 | |
| FQTWMVPAVRVDFYN | 186 | O95461 | |
| FVWGLDAPQRMYSEI | 376 | Q5VXI9 | |
| EVINYEPIGYATDMW | 1631 | Q15746 | |
| CVPVDASRYFFDEWM | 96 | P28336 | |
| DNGYPWDMLLVTRFG | 226 | P31513 | |
| FTFDDYAMHWVRQAP | 46 | P0DP04 | |
| QFLWGPRAYTETSKM | 201 | Q9BZ81 | |
| EFLWGPRAYAETTKM | 356 | Q8N7X4 | |
| LAFPEFSWRGYAQMT | 751 | Q16787 | |
| FGERPYWDMSNQDVI | 816 | P54760 | |
| FGTVEYWFRLRVPMD | 726 | Q68CZ1 | |
| EELCRRWMQLGAFYP | 616 | Q2M2H8 | |
| PEVYALGVRNMWRCS | 386 | Q96JK4 | |
| YQNVRGRPIFWMEKD | 271 | Q93015 | |
| MVLDWATGTLYPGRF | 186 | Q86W26 | |
| FTFDDYAMHWVRQAP | 46 | P01782 | |
| PEELCRRWMQLGAFY | 666 | O43451 | |
| EPARSLWISMQDYAV | 1231 | Q15751 | |
| IYCARPGSRMWEVNF | 236 | Q9UPZ3 | |
| MALFIQPYWIGDSVN | 41 | Q8TAF8 | |
| MAFRWVTEFCPNAKY | 161 | O75752 | |
| GGQTYEMFSWFLRPL | 216 | Q96SQ9 | |
| WQMNPYDRGSAFAIG | 91 | Q92499 | |
| MSFYAAKRVIGDNPW | 221 | Q5VYK3 | |
| PRHPAAMSWYEEFQR | 61 | Q969U6 | |
| YMFIWNGEVSPNLFE | 56 | Q75LS8 | |
| WITFSDPRAMAEKGY | 196 | Q6UWM7 | |
| ARFINWMEEEFNYPL | 136 | P06858 | |
| DLRFWLGDMYTPGFD | 136 | P59773 | |
| MYDLKVPRWDFQTGR | 441 | Q8NCN5 | |
| PLYDRLDAQGARWME | 461 | Q8NCN5 | |
| YEFVSFPTDMWSVGV | 686 | Q32MK0 | |
| VPSSMFRLDENYQPW | 471 | P22079 | |
| MAWGQYIDHDIAFTP | 231 | P07202 | |
| FLGWSVLNPDTYESM | 426 | P16499 | |
| FFDVWSVLMGESQPY | 286 | P35913 | |
| GFMSYIVEPLFREWA | 376 | Q9NP56 | |
| SSPDYQIRWSAGRMI | 171 | Q14999 | |
| LSGSDDFNLYMWRIP | 296 | Q96JK2 | |
| IYFPIRDSWNAGIMT | 76 | Q5XKP0 | |
| RAIALDPSSGFMYWT | 141 | O75581 | |
| EFGLDYPEGMAVDWL | 701 | O75581 | |
| RALALDPAEGFMYWT | 751 | O75581 | |
| FTFDDYGMSWVRQAP | 46 | A0A0C4DH32 | |
| AFGERPYWDMSGQDV | 841 | Q5JZY3 | |
| VLERSMDFGRTYQPW | 171 | O15230 | |
| SYTRQEFVDMEGWVL | 1641 | O15230 | |
| FQLISEPMFGDYWIV | 171 | Q6IE36 | |
| EPMFGDYWIVVKRNS | 176 | Q6IE36 | |
| RSAWYMGPVSRQEAQ | 11 | P46109 | |
| FTFGDYAMSWVRQAP | 46 | A0A0A0MS15 | |
| TVGDVALYMAFFPVW | 331 | Q9H490 | |
| MFEYVRNDRDGWNPS | 311 | O77932 | |
| LMSEWERSYFGNMGP | 566 | P22557 | |
| YGRQAPVGMSDVWLT | 481 | Q9Y3Q4 | |
| FTFDDYTMHWVRQAP | 46 | A0A0B4J1X8 | |
| DAWMFPLGDEVYSRI | 296 | Q13093 | |
| EIEYRMARGPWAEVH | 321 | Q92729 | |
| YKRENPGMFSWEIRD | 121 | P23760 | |
| NYLFEQPSSRSMIWD | 216 | Q7RTY9 | |
| FVSPQLGYWVAAMAS | 281 | A8MVW0 | |
| FGDMAWVPFTYSLQA | 261 | O76062 | |
| SDLAAESNFRIYPWM | 116 | P09629 | |
| ESNFRIYPWMRSSGT | 121 | P09629 | |
| FVMRNDFLWDYAEPG | 396 | Q5T6X5 | |
| FLYWTGPNMEVDTLD | 51 | Q01970 | |
| GTRVDSSNYMPQLFW | 651 | Q01970 | |
| WPVNIVAFAYAVMSR | 281 | Q7Z6L0 | |
| LGMSWAGAEPLRYFV | 21 | Q9Y5E2 | |
| PTGWNNVFYMLISAD | 456 | Q8TED4 | |
| NTREPVMLACYVWGF | 126 | P28068 | |
| ARVDSGCWMLYEQPN | 36 | P07320 | |
| DMNRLEERYGWLAAP | 586 | Q04446 | |
| SDEWTEGLPMLNARY | 346 | Q8NBE8 | |
| VEMYFPQNDSWIGLA | 301 | Q9NXS3 | |
| YQECQGTIPWFMEIR | 506 | P20023 | |
| GKYRMPFAWAVRSVF | 551 | Q96BY6 | |
| VCSRLGQYRMPFAWA | 516 | Q5JSL3 | |
| WMAPEALFDRIYTHQ | 666 | P11362 | |
| ENMTYGLVFLFAPAW | 46 | Q8N5C1 | |
| VLFDAVVTAPMEAYW | 726 | Q7Z3S7 | |
| FCRESRYMDQWVPVI | 146 | P24522 | |
| YTGWRADRPFAIDMA | 231 | Q9NPZ5 | |
| SPSAEAEYWRIRAMA | 1651 | Q5TH69 | |
| PWASLYFVALMTFGN | 836 | Q9P0X4 | |
| ISRIFDSGYPWDMVF | 221 | Q01740 | |
| DSGYPWDMVFMTRFQ | 226 | Q01740 | |
| ARAVDLIPWMEYEFR | 666 | Q12860 | |
| YARADPTMGRIWVDA | 156 | Q9NQT6 | |
| TPWMDYEFRVIASNI | 676 | Q02246 | |
| NVLEGSWILYEMPNY | 126 | P07316 | |
| QTLMFLVRDWSFPYE | 206 | Q6DD88 | |
| MTWAYAAGVPLASDR | 36 | Q92839 | |
| ASYDGQDPEFLMIWV | 1581 | Q8TEP8 | |
| WGMSYDELCFLEQRP | 146 | Q8WWZ3 | |
| FAPGAMENWGLITYR | 331 | Q6P179 | |
| MSRISEDGYPWDSVF | 221 | Q99518 | |
| EGMWLRYNFQAPATN | 1011 | Q9UHC6 | |
| GAGSLVDVMPWLQYF | 236 | Q16678 | |
| IRVESGCWMLYERPN | 36 | P07315 | |
| LFDINRWYHAQMPDS | 401 | Q8WYP5 | |
| LGSMYRPVNWRANDT | 236 | Q17R55 | |
| LYGWTMEPVFVCQRA | 176 | P35212 | |
| YVAMSLRPAAGAWER | 31 | Q9NYC9 | |
| ALYFDMVPESWARRA | 4296 | Q9NYC9 | |
| WNQFFVLEEYMGSDP | 51 | Q9ULB5 | |
| FWDTEEAYIGSMRPL | 1191 | Q9Y4K1 | |
| WTVSEKFNMPRGYIQ | 951 | Q8TDG4 | |
| FYPEFVRSLNMSWRE | 276 | Q16478 | |
| LVMNVYRDGAWGAFR | 1501 | P49327 | |
| CEEAPLGRAYTQTWM | 11 | Q1T7F1 | |
| ETDRGMSAEYSFPIW | 206 | Q9Y512 | |
| FQLGTFPDWADMYSV | 571 | Q8WWT9 | |
| FPDWADMYSVNVTAL | 576 | Q8WWT9 | |
| YFTMQVRELPRGEWQ | 1511 | Q7Z5N4 | |
| RAFWYGQLSGMVEPL | 261 | Q8N1S5 | |
| RWYFEFEAVTTGEMR | 1086 | P21817 | |
| YEPFAVNTNRDITMW | 1236 | Q92736 | |
| EPEAWTAAAMYQATR | 221 | Q13895 | |
| AMGFELPWVYFVSLV | 376 | Q01668 | |
| GAAEANFRIYPWMRS | 111 | P31268 | |
| FAAIMYVPALGWEFL | 131 | Q96RD6 | |
| YGAVREGPWVNIFME | 456 | Q99558 | |
| TMAHLYGDPEWSQRD | 366 | Q86XP0 | |
| LMFADWVEFSPYEIG | 341 | P47712 | |
| STVYLMNSWPFGDVL | 116 | P41145 | |
| PWVDNIVSRMVFYFH | 396 | Q6ZUA9 | |
| IQMYFEWSDGTPVTF | 431 | P22897 | |
| HLERANMFEYLPTWV | 401 | A6ND36 | |
| PDAVFRLMEQCWAYE | 786 | P07332 | |
| DGWRYMLGLAAVPAV | 236 | Q96QE2 | |
| MWQAIRASSAAPGYF | 601 | Q9NP80 | |
| MAAEVLPSARWQYCG | 1 | Q9GZS1 | |
| MYQGFWSEADVTRPF | 341 | Q9NP92 | |
| MAGQFRSYVWDPLLI | 1 | Q8N2H4 | |
| DWDSPYLDMELARAG | 351 | Q9H987 | |
| GFTGLDLEEQWMYPS | 226 | A2RUB1 | |
| GMLYINFSALWDPVI | 726 | O75691 | |
| DVMNYFAWERNPSTI | 126 | Q06141 | |
| WVMSELPGRGVQLYD | 131 | Q96IW2 | |
| ENVDWYDVRMLLPQF | 576 | O60522 | |
| GDMICAVFPEDNLWY | 1356 | O60522 | |
| GGRVDSSNYMPQIFW | 626 | Q15147 | |
| SDSADPFYWMRVILA | 56 | Q9H9S3 | |
| PFYWMRVILASNRGT | 61 | Q9H9S3 | |
| QWFNAPFAMTGERVD | 911 | P51531 | |
| GLTVWFPDMIRYFQD | 406 | Q7L1I2 | |
| LTYMLGPDWQFDITD | 586 | Q14DG7 | |
| DFMGLITLEYAVPWF | 111 | Q8NBD8 | |
| IWFMDYGSSEAIPSI | 321 | B5MCY1 | |
| WEVFTEGRMPFEKYT | 556 | P42680 | |
| RMFSGVGVYLVDAWE | 511 | Q969Y0 | |
| MGESLEPASLFVYVW | 591 | Q86YW0 | |
| WVRPDMKYIGFETVN | 306 | Q9P2J5 | |
| ARLWYDMLGVPEDGS | 346 | P21675 | |
| EPELLVRWYQMGAYQ | 656 | Q14697 | |
| TWMYFSAADPIRDTN | 536 | Q9BQS7 | |
| PYGFSAMQGWRVSME | 26 | O15355 | |
| MVIAYFSRAGLPSWQ | 141 | P0DUX0 | |
| MVIAYFSRAGLPSWQ | 141 | P0DTA3 | |
| MVIAYFSRAGLPSWQ | 141 | P0DUD1 | |
| RPLMSDQNAASWGYF | 191 | Q9UHJ6 | |
| MDTPRGIGTFVVWDY | 1 | Q8N695 | |
| MWYVSTRGVAPRVNF | 1 | Q86YJ6 | |
| SQMAEPFRTFRDGWV | 286 | Q9NP59 | |
| TVFIFWGPSSYMRRD | 166 | Q9BVH7 | |
| NYVRDTLSNPRGWMA | 2601 | P08F94 | |
| TRRNWESNYFGMPLQ | 1251 | Q13017 | |
| APLFISGMRDDYFWD | 221 | P0C7M4 | |
| NFGLVEVVYEWARGM | 1166 | Q15477 | |
| EVVYEWARGMPFSEL | 1171 | Q15477 | |
| MGEIKVSPDYNWFRG | 1 | Q9NZD8 | |
| IRDYGEPFQEAMWLD | 606 | Q9HB58 | |
| MFPTRWLDFAGVYSA | 91 | Q5SWA1 | |
| MISFDVFPEGWDKRY | 186 | Q92871 | |
| DLQTWMGSPSIFVYD | 181 | Q8N122 | |
| VWFPDMIRHLQAVDY | 466 | Q7L0J3 | |
| IFGWQLPNTRYIADM | 51 | Q96DG6 | |
| WIYRVDPTRVNEFGM | 586 | O96005 | |
| RKGPSFADMEVLYWT | 381 | Q6IBW4 | |
| AFGGATMWDYTIPIL | 206 | Q8WUD6 | |
| QWSRPFLDMVYHALD | 476 | Q2KHT3 | |
| QSSPFYFWMNGDRID | 146 | P10909 | |
| LWEMYRTEPLAANPF | 131 | Q9UKZ1 | |
| DEVFVFPYDMGSRWR | 256 | Q9H6R6 | |
| FPYDMGSRWRNFKQV | 261 | Q9H6R6 | |
| DGALYLMAERIAWAP | 21 | P32780 | |
| NPFLSDTWSMGVILY | 216 | Q6SA08 | |
| RANMVWRPDTGFFAY | 1121 | Q96KV7 | |
| FYMLVEFAVGQLPWR | 226 | Q5TCY1 | |
| GSWLREYPVTLMQFF | 1861 | Q8IZQ1 | |
| DSRYQQWMERFGPDT | 351 | Q9BQ52 | |
| SIYEDWDPFRFRHMI | 1321 | Q13009 | |
| QVFLVPYAMWHSVDE | 256 | O15375 | |
| PFLLADAMCVGYDQW | 121 | Q9UGH3 | |
| SDSADPFYWMRVILA | 56 | P61619 | |
| PFYWMRVILASNRGT | 61 | P61619 | |
| MGLEALVESYAFWRP | 336 | O95935 | |
| MVIAYFSRAGLPSWQ | 141 | P0DUX1 | |
| MVIAYFSRAGLPSWQ | 141 | A0A494C0Z2 | |
| MVIAYFSRAGLPSWQ | 141 | P0DUD3 | |
| MVIAYFSRAGLPSWQ | 141 | P0DUD4 | |
| MVIAYFSRAGLPSWQ | 141 | P0DUD2 | |
| GDLTVKMWRVFPYAE | 616 | A6NE52 | |
| RVASNPYTWFTMEAL | 2161 | Q13813 | |
| WYAGPMERAGAESIL | 671 | P15498 | |
| WEEAARRLEVAMYPF | 411 | Q9NZV5 | |
| AMVIAYFSRAGFPSW | 186 | Q8NFV5 | |
| WTVAQGPFDSFMVQY | 1281 | P22105 | |
| WPAELMQGLARYVFQ | 136 | Q9UMX1 | |
| TIFGFTMEERSWGPY | 371 | P20061 | |
| VMREGTRNWFTDLEY | 121 | Q86UE3 | |
| FPYARLGWAMTSADL | 376 | P80108 | |
| VDGEWLAELGPMFYS | 1136 | Q92620 | |
| WMELYPAVSTDVRFA | 516 | Q6NWY9 | |
| AWQSLPDFGISYVMV | 546 | Q86UX7 | |
| APLFISGMRDDYFWD | 221 | Q9BQY4 | |
| SPLLYVMENEVDAFW | 461 | Q8TC07 | |
| VNRMEEGNPRLWYAA | 191 | Q13530 | |
| GTRVDSSNYMPQLFW | 601 | Q9NQ66 | |
| EESPGVIYCISMQWF | 811 | Q9Y2K6 | |
| PAIMNSCVFGIWRYE | 61 | Q8TCE9 | |
| SRFQYPFHELMVWAV | 606 | Q7Z4N2 | |
| MRDSVARIYPFWTPD | 161 | Q5R3I4 | |
| YQGPRDFQTLENWML | 151 | Q8NBS9 | |
| MVIAYFSRAGLPSWQ | 141 | A0A494C191 | |
| YAVFSQLMETAEPWF | 251 | Q92609 | |
| KRTEPGWSFCEYFMV | 211 | P48553 | |
| APRGLYNSVDSWMIV | 476 | Q9UJV3 | |
| EGVVPNRFYWSVMGS | 311 | Q8WY21 | |
| NRFYWSVMGSNKEPD | 316 | Q8WY21 | |
| PSDAMAWAYTIFENI | 431 | Q2TAA8 | |
| IGQAMWLAPAYVLEF | 366 | Q9H3S5 | |
| GRGFTVWEPYMDVSA | 1206 | Q9Y4E6 | |
| ERLSYAFSVWRMEGA | 181 | Q15672 | |
| GYRWMFETQPLDQLG | 511 | Q702N8 | |
| DDDMFNHQVPYLWLI | 1736 | O60293 | |
| MAQDTGIPADIWRFY | 606 | P56192 | |
| EDLRFPGMWVSLYFG | 6 | Q6PEX7 | |
| NWFRAECLMDYDPRG | 266 | C9JLR9 | |
| IMGAFLVEAWYSRNV | 246 | B6A8C7 | |
| FLSDYGLQWVGEPMD | 146 | Q5T124 | |
| PWYAGAMERLQAETE | 671 | Q9UKW4 | |
| FSQEERMAAGYLPRW | 26 | Q86TJ5 | |
| RMWALFEDPYSSRAA | 211 | Q03721 | |
| RYEEMTERWFPLANN | 221 | Q9P2K6 | |
| AIVVDPVHGFMYWTD | 521 | P01130 | |
| NYTKAMRLFVGEPVW | 141 | Q9BV57 | |
| MRLFVGEPVWTAYNR | 146 | Q9BV57 | |
| AASQEGWVFLMYRAI | 276 | Q8IZF0 | |
| GWVFLMYRAIDSFPR | 281 | Q8IZF0 | |
| AMQFSIPPWRYDAEV | 586 | Q6NSJ0 | |
| FKTYISPWERAMGVD | 181 | Q9NP98 | |
| CADARMYGVLPWNAF | 201 | P60201 |